Motif ID: Klf4_Sp3
Z-value: 1.655
Transcription factors associated with Klf4_Sp3:
| Gene Symbol | Entrez ID | Gene Name |
|---|---|---|
| Klf4 | ENSMUSG00000003032.8 | Klf4 |
| Sp3 | ENSMUSG00000027109.10 | Sp3 |
Activity-expression correlation:
| Gene Symbol | Promoter | Pearson corr. coef. | P-value | Plot |
|---|---|---|---|---|
| Sp3 | mm10_v2_chr2_-_72980402_72980471 | -0.70 | 1.3e-03 | Click! |
| Klf4 | mm10_v2_chr4_-_55532453_55532485 | 0.28 | 2.5e-01 | Click! |
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.8 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
| 2.2 | 6.7 | GO:0046022 | regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 1.7 | 6.9 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
| 1.7 | 8.5 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
| 1.7 | 6.8 | GO:0030091 | protein repair(GO:0030091) |
| 1.7 | 6.7 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
| 1.6 | 4.9 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 1.5 | 1.5 | GO:1900141 | regulation of oligodendrocyte apoptotic process(GO:1900141) negative regulation of oligodendrocyte apoptotic process(GO:1900142) |
| 1.5 | 4.4 | GO:0060129 | thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
| 1.4 | 2.9 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
| 1.4 | 5.6 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
| 1.4 | 4.1 | GO:1902162 | regulation of DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:1902162) |
| 1.4 | 4.1 | GO:0030200 | heparan sulfate proteoglycan catabolic process(GO:0030200) |
| 1.3 | 2.6 | GO:0061054 | dermatome development(GO:0061054) regulation of dermatome development(GO:0061183) |
| 1.3 | 3.9 | GO:0003360 | brainstem development(GO:0003360) |
| 1.2 | 6.2 | GO:2000774 | positive regulation of cellular senescence(GO:2000774) |
| 1.2 | 3.6 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
| 1.2 | 1.2 | GO:0031547 | brain-derived neurotrophic factor receptor signaling pathway(GO:0031547) |
| 1.2 | 1.2 | GO:0070366 | regulation of hepatocyte differentiation(GO:0070366) |
| 1.2 | 5.9 | GO:0035262 | gonad morphogenesis(GO:0035262) |
| 1.2 | 3.5 | GO:0060167 | regulation of adenosine receptor signaling pathway(GO:0060167) |
| 1.1 | 3.3 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
| 1.1 | 2.2 | GO:0003195 | tricuspid valve formation(GO:0003195) |
| 1.1 | 6.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
| 1.1 | 3.2 | GO:0072180 | mesonephric duct development(GO:0072177) mesonephric duct morphogenesis(GO:0072180) |
| 1.0 | 5.2 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
| 1.0 | 3.1 | GO:0060672 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
| 1.0 | 4.0 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
| 1.0 | 4.0 | GO:0006529 | asparagine biosynthetic process(GO:0006529) |
| 1.0 | 3.0 | GO:2000744 | anterior head development(GO:0097065) regulation of anterior head development(GO:2000742) positive regulation of anterior head development(GO:2000744) |
| 1.0 | 2.9 | GO:0060598 | dichotomous subdivision of terminal units involved in mammary gland duct morphogenesis(GO:0060598) |
| 1.0 | 2.9 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
| 1.0 | 2.9 | GO:0030421 | defecation(GO:0030421) |
| 0.9 | 1.9 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
| 0.9 | 3.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
| 0.9 | 2.7 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
| 0.9 | 3.7 | GO:1902268 | negative regulation of polyamine transmembrane transport(GO:1902268) |
| 0.9 | 2.7 | GO:0009153 | purine deoxyribonucleotide biosynthetic process(GO:0009153) |
| 0.9 | 0.9 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.9 | 2.7 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
| 0.9 | 2.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
| 0.9 | 0.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
| 0.9 | 0.9 | GO:0090202 | transcriptional activation by promoter-enhancer looping(GO:0071733) gene looping(GO:0090202) dsDNA loop formation(GO:0090579) |
| 0.8 | 5.9 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
| 0.8 | 2.5 | GO:0001193 | maintenance of transcriptional fidelity during DNA-templated transcription elongation(GO:0001192) maintenance of transcriptional fidelity during DNA-templated transcription elongation from RNA polymerase II promoter(GO:0001193) |
| 0.8 | 0.8 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
| 0.8 | 2.5 | GO:0097401 | synaptic vesicle lumen acidification(GO:0097401) |
| 0.8 | 1.6 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
| 0.8 | 3.2 | GO:0010288 | response to lead ion(GO:0010288) |
| 0.8 | 4.8 | GO:0046985 | positive regulation of hemoglobin biosynthetic process(GO:0046985) |
| 0.8 | 6.4 | GO:1990845 | adaptive thermogenesis(GO:1990845) |
| 0.8 | 3.2 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
| 0.8 | 1.6 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
| 0.8 | 4.6 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) |
| 0.8 | 3.0 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
| 0.8 | 6.0 | GO:0008343 | adult feeding behavior(GO:0008343) |
| 0.8 | 5.3 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
| 0.7 | 2.2 | GO:0086047 | membrane depolarization during Purkinje myocyte cell action potential(GO:0086047) |
| 0.7 | 3.7 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
| 0.7 | 2.2 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
| 0.7 | 2.2 | GO:0071707 | immunoglobulin heavy chain V-D-J recombination(GO:0071707) |
| 0.7 | 2.2 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
| 0.7 | 2.2 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
| 0.7 | 2.9 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
| 0.7 | 0.7 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
| 0.7 | 2.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
| 0.7 | 2.1 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
| 0.7 | 4.9 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
| 0.7 | 2.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
| 0.7 | 8.4 | GO:0002176 | male germ cell proliferation(GO:0002176) |
| 0.7 | 0.7 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) positive regulation of NAD(P)H oxidase activity(GO:0033864) |
| 0.7 | 2.8 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
| 0.7 | 2.1 | GO:0036166 | phenotypic switching(GO:0036166) |
| 0.7 | 2.1 | GO:0060217 | hemangioblast cell differentiation(GO:0060217) regulation of mast cell differentiation(GO:0060375) |
| 0.7 | 2.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
| 0.7 | 2.0 | GO:1904046 | negative regulation of vascular endothelial growth factor production(GO:1904046) |
| 0.7 | 0.7 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
| 0.7 | 2.0 | GO:1901355 | response to rapamycin(GO:1901355) |
| 0.7 | 0.7 | GO:0030916 | otic vesicle formation(GO:0030916) |
| 0.7 | 3.9 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
| 0.7 | 2.0 | GO:1990523 | bone regeneration(GO:1990523) |
| 0.7 | 2.0 | GO:0006226 | dUMP biosynthetic process(GO:0006226) |
| 0.6 | 1.9 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
| 0.6 | 0.6 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
| 0.6 | 2.5 | GO:0072369 | regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter(GO:0072369) |
| 0.6 | 1.9 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
| 0.6 | 5.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.6 | 3.1 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.6 | 0.6 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
| 0.6 | 3.1 | GO:0060266 | negative regulation of respiratory burst involved in inflammatory response(GO:0060266) |
| 0.6 | 1.2 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.6 | 1.9 | GO:0098974 | postsynaptic actin cytoskeleton organization(GO:0098974) |
| 0.6 | 2.5 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
| 0.6 | 2.4 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
| 0.6 | 3.0 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.6 | 3.6 | GO:0007253 | cytoplasmic sequestering of NF-kappaB(GO:0007253) |
| 0.6 | 14.9 | GO:0048385 | regulation of retinoic acid receptor signaling pathway(GO:0048385) |
| 0.6 | 4.2 | GO:2000124 | regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.6 | 1.2 | GO:0014842 | skeletal muscle satellite cell proliferation(GO:0014841) regulation of skeletal muscle satellite cell proliferation(GO:0014842) skeletal muscle cell proliferation(GO:0014856) regulation of skeletal muscle cell proliferation(GO:0014857) |
| 0.6 | 1.8 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
| 0.6 | 0.6 | GO:0031990 | mRNA export from nucleus in response to heat stress(GO:0031990) |
| 0.6 | 1.8 | GO:0046356 | acetyl-CoA catabolic process(GO:0046356) |
| 0.6 | 2.4 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
| 0.6 | 1.7 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
| 0.6 | 1.2 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
| 0.6 | 1.2 | GO:0070318 | positive regulation of G0 to G1 transition(GO:0070318) |
| 0.6 | 1.7 | GO:0032275 | luteinizing hormone secretion(GO:0032275) |
| 0.6 | 1.1 | GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process(GO:0010512) |
| 0.6 | 1.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
| 0.6 | 4.0 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
| 0.6 | 1.7 | GO:0070172 | positive regulation of tooth mineralization(GO:0070172) |
| 0.6 | 0.6 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
| 0.6 | 1.1 | GO:0043096 | purine nucleobase salvage(GO:0043096) |
| 0.6 | 5.1 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) |
| 0.6 | 1.7 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
| 0.6 | 5.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
| 0.6 | 2.2 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
| 0.6 | 0.6 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
| 0.6 | 5.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
| 0.6 | 0.6 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
| 0.5 | 1.6 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
| 0.5 | 2.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.5 | 1.6 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
| 0.5 | 2.7 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
| 0.5 | 0.5 | GO:1905072 | cardiac jelly development(GO:1905072) |
| 0.5 | 1.6 | GO:0070278 | extracellular matrix constituent secretion(GO:0070278) |
| 0.5 | 5.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.5 | 2.1 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
| 0.5 | 2.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
| 0.5 | 3.2 | GO:0061732 | mitochondrial acetyl-CoA biosynthetic process from pyruvate(GO:0061732) |
| 0.5 | 0.5 | GO:0032241 | positive regulation of nucleobase-containing compound transport(GO:0032241) |
| 0.5 | 3.2 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
| 0.5 | 4.2 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
| 0.5 | 1.6 | GO:0048254 | snoRNA localization(GO:0048254) |
| 0.5 | 1.6 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
| 0.5 | 6.8 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
| 0.5 | 1.0 | GO:0072143 | mesangial cell differentiation(GO:0072007) glomerular mesangial cell differentiation(GO:0072008) mesangial cell development(GO:0072143) glomerular mesangial cell development(GO:0072144) pericyte cell differentiation(GO:1904238) |
| 0.5 | 0.5 | GO:0072061 | inner medullary collecting duct development(GO:0072061) |
| 0.5 | 0.5 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
| 0.5 | 3.6 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
| 0.5 | 3.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
| 0.5 | 1.5 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.5 | 5.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.5 | 1.0 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
| 0.5 | 10.8 | GO:0044458 | motile cilium assembly(GO:0044458) |
| 0.5 | 3.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.5 | 2.5 | GO:0019659 | fermentation(GO:0006113) glucose catabolic process to lactate(GO:0019659) glycolytic fermentation(GO:0019660) glucose catabolic process to lactate via pyruvate(GO:0019661) |
| 0.5 | 1.5 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
| 0.5 | 2.0 | GO:0006048 | UDP-N-acetylglucosamine biosynthetic process(GO:0006048) |
| 0.5 | 2.0 | GO:0030576 | Cajal body organization(GO:0030576) |
| 0.5 | 2.0 | GO:1905063 | regulation of vascular smooth muscle cell differentiation(GO:1905063) |
| 0.5 | 4.0 | GO:0006729 | tetrahydrobiopterin biosynthetic process(GO:0006729) tetrahydrobiopterin metabolic process(GO:0046146) |
| 0.5 | 1.0 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
| 0.5 | 3.4 | GO:0032511 | late endosome to vacuole transport via multivesicular body sorting pathway(GO:0032511) |
| 0.5 | 2.5 | GO:1900186 | negative regulation of clathrin-mediated endocytosis(GO:1900186) |
| 0.5 | 1.5 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
| 0.5 | 1.4 | GO:2001206 | positive regulation of osteoclast development(GO:2001206) |
| 0.5 | 3.4 | GO:0072081 | proximal/distal pattern formation involved in nephron development(GO:0072047) specification of nephron tubule identity(GO:0072081) specification of loop of Henle identity(GO:0072086) |
| 0.5 | 1.4 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
| 0.5 | 1.4 | GO:1902219 | negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
| 0.5 | 0.5 | GO:0032274 | gonadotropin secretion(GO:0032274) |
| 0.5 | 0.9 | GO:0042473 | outer ear morphogenesis(GO:0042473) |
| 0.5 | 1.9 | GO:2000546 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
| 0.5 | 1.4 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
| 0.5 | 0.5 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
| 0.5 | 2.4 | GO:0015705 | iodide transport(GO:0015705) |
| 0.5 | 1.4 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
| 0.5 | 3.3 | GO:0044829 | positive regulation by host of viral genome replication(GO:0044829) |
| 0.5 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
| 0.5 | 1.4 | GO:0030043 | actin filament fragmentation(GO:0030043) |
| 0.5 | 1.9 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
| 0.5 | 4.6 | GO:0036123 | histone H3-K9 dimethylation(GO:0036123) |
| 0.5 | 0.9 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
| 0.5 | 10.2 | GO:0035036 | binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.5 | 1.4 | GO:0042275 | error-free postreplication DNA repair(GO:0042275) |
| 0.5 | 0.5 | GO:0097201 | negative regulation of transcription from RNA polymerase II promoter in response to stress(GO:0097201) |
| 0.5 | 1.8 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
| 0.5 | 2.8 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate metabolic process(GO:0046490) |
| 0.5 | 1.4 | GO:0070245 | positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.5 | 1.4 | GO:0031660 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031660) positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G2/M transition of mitotic cell cycle(GO:0031662) |
| 0.5 | 1.4 | GO:0009446 | putrescine biosynthetic process(GO:0009446) |
| 0.5 | 5.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.5 | 1.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
| 0.5 | 0.9 | GO:2000016 | negative regulation of determination of dorsal identity(GO:2000016) |
| 0.4 | 0.4 | GO:0060216 | definitive hemopoiesis(GO:0060216) |
| 0.4 | 0.4 | GO:0033128 | negative regulation of histone phosphorylation(GO:0033128) |
| 0.4 | 1.8 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
| 0.4 | 0.9 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
| 0.4 | 4.4 | GO:0001977 | renal system process involved in regulation of blood volume(GO:0001977) |
| 0.4 | 2.2 | GO:0052428 | modulation of molecular function in other organism(GO:0044359) negative regulation of molecular function in other organism(GO:0044362) negative regulation of molecular function in other organism involved in symbiotic interaction(GO:0052204) modulation of molecular function in other organism involved in symbiotic interaction(GO:0052205) negative regulation by host of symbiont molecular function(GO:0052405) modification by host of symbiont molecular function(GO:0052428) |
| 0.4 | 1.3 | GO:0006546 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
| 0.4 | 3.0 | GO:0046549 | retinal cone cell development(GO:0046549) |
| 0.4 | 0.4 | GO:0036118 | hyaluranon cable assembly(GO:0036118) regulation of hyaluranon cable assembly(GO:1900104) positive regulation of hyaluranon cable assembly(GO:1900106) |
| 0.4 | 1.7 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
| 0.4 | 2.1 | GO:0016264 | gap junction assembly(GO:0016264) |
| 0.4 | 1.7 | GO:0060709 | glycogen cell differentiation involved in embryonic placenta development(GO:0060709) |
| 0.4 | 1.3 | GO:0001842 | neural fold formation(GO:0001842) |
| 0.4 | 1.7 | GO:0015825 | L-serine transport(GO:0015825) |
| 0.4 | 1.3 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
| 0.4 | 2.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
| 0.4 | 0.9 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
| 0.4 | 0.4 | GO:1902512 | positive regulation of apoptotic DNA fragmentation(GO:1902512) |
| 0.4 | 3.0 | GO:1990416 | cellular response to brain-derived neurotrophic factor stimulus(GO:1990416) |
| 0.4 | 2.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
| 0.4 | 4.2 | GO:0035873 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
| 0.4 | 4.2 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
| 0.4 | 2.1 | GO:0051031 | tRNA transport(GO:0051031) |
| 0.4 | 0.4 | GO:0014834 | skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration(GO:0014834) |
| 0.4 | 0.8 | GO:0019401 | alditol biosynthetic process(GO:0019401) |
| 0.4 | 0.8 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
| 0.4 | 1.7 | GO:0019355 | nicotinamide nucleotide biosynthetic process from aspartate(GO:0019355) 'de novo' NAD biosynthetic process(GO:0034627) 'de novo' NAD biosynthetic process from aspartate(GO:0034628) |
| 0.4 | 2.9 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
| 0.4 | 0.4 | GO:0015744 | succinate transport(GO:0015744) |
| 0.4 | 1.2 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
| 0.4 | 1.2 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
| 0.4 | 1.2 | GO:2000642 | negative regulation of early endosome to late endosome transport(GO:2000642) |
| 0.4 | 4.1 | GO:1901070 | guanosine-containing compound biosynthetic process(GO:1901070) |
| 0.4 | 0.4 | GO:0030860 | regulation of polarized epithelial cell differentiation(GO:0030860) |
| 0.4 | 1.2 | GO:0007354 | zygotic determination of anterior/posterior axis, embryo(GO:0007354) |
| 0.4 | 3.3 | GO:0018158 | protein oxidation(GO:0018158) |
| 0.4 | 1.2 | GO:0016132 | brassinosteroid metabolic process(GO:0016131) brassinosteroid biosynthetic process(GO:0016132) |
| 0.4 | 2.0 | GO:0086045 | membrane depolarization during AV node cell action potential(GO:0086045) |
| 0.4 | 2.0 | GO:0034969 | histone arginine methylation(GO:0034969) |
| 0.4 | 0.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.4 | 2.4 | GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest(GO:0006977) |
| 0.4 | 1.2 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
| 0.4 | 1.6 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
| 0.4 | 1.2 | GO:0006059 | hexitol metabolic process(GO:0006059) |
| 0.4 | 2.8 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
| 0.4 | 1.6 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
| 0.4 | 1.6 | GO:0032627 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) |
| 0.4 | 1.2 | GO:0051383 | kinetochore organization(GO:0051383) |
| 0.4 | 2.0 | GO:0038030 | non-canonical Wnt signaling pathway via MAPK cascade(GO:0038030) non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
| 0.4 | 0.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
| 0.4 | 1.6 | GO:0030202 | heparin metabolic process(GO:0030202) |
| 0.4 | 1.9 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
| 0.4 | 0.4 | GO:0006625 | protein targeting to peroxisome(GO:0006625) peroxisomal transport(GO:0043574) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
| 0.4 | 0.8 | GO:1904578 | response to thapsigargin(GO:1904578) cellular response to thapsigargin(GO:1904579) |
| 0.4 | 3.0 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
| 0.4 | 1.5 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
| 0.4 | 0.8 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.4 | 0.4 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
| 0.4 | 2.6 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
| 0.4 | 5.6 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.4 | 1.9 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.4 | 2.2 | GO:0044351 | macropinocytosis(GO:0044351) |
| 0.4 | 1.5 | GO:2000630 | positive regulation of miRNA metabolic process(GO:2000630) |
| 0.4 | 1.1 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
| 0.4 | 1.9 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
| 0.4 | 1.5 | GO:0003342 | proepicardium development(GO:0003342) septum transversum development(GO:0003343) |
| 0.4 | 1.1 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
| 0.4 | 0.7 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
| 0.4 | 2.2 | GO:0021539 | subthalamus development(GO:0021539) |
| 0.4 | 1.8 | GO:0023041 | neuronal signal transduction(GO:0023041) |
| 0.4 | 0.7 | GO:0072194 | ureter smooth muscle development(GO:0072191) ureter smooth muscle cell differentiation(GO:0072193) kidney smooth muscle tissue development(GO:0072194) |
| 0.4 | 3.7 | GO:0048537 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) |
| 0.4 | 1.5 | GO:0010940 | positive regulation of necrotic cell death(GO:0010940) |
| 0.4 | 0.7 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
| 0.4 | 5.4 | GO:0006924 | activation-induced cell death of T cells(GO:0006924) |
| 0.4 | 2.9 | GO:0035437 | maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.4 | 2.2 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
| 0.4 | 1.8 | GO:0035360 | positive regulation of peroxisome proliferator activated receptor signaling pathway(GO:0035360) |
| 0.4 | 2.2 | GO:1903755 | regulation of SUMO transferase activity(GO:1903182) positive regulation of SUMO transferase activity(GO:1903755) |
| 0.4 | 1.8 | GO:0045918 | negative regulation of cytolysis(GO:0045918) |
| 0.4 | 0.7 | GO:0071474 | cellular hyperosmotic response(GO:0071474) |
| 0.4 | 1.1 | GO:0009838 | abscission(GO:0009838) |
| 0.4 | 2.1 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
| 0.4 | 0.4 | GO:0090272 | negative regulation of fibroblast growth factor production(GO:0090272) |
| 0.4 | 0.7 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
| 0.4 | 0.4 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
| 0.4 | 1.1 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.3 | 3.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
| 0.3 | 0.7 | GO:0019405 | alditol catabolic process(GO:0019405) |
| 0.3 | 1.0 | GO:0046061 | dATP catabolic process(GO:0046061) |
| 0.3 | 1.4 | GO:0051036 | regulation of endosome size(GO:0051036) |
| 0.3 | 1.4 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
| 0.3 | 1.0 | GO:1903630 | regulation of aminoacyl-tRNA ligase activity(GO:1903630) positive regulation of aminoacyl-tRNA ligase activity(GO:1903632) |
| 0.3 | 1.0 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.3 | 0.7 | GO:0045869 | negative regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045869) |
| 0.3 | 1.0 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.3 | 0.3 | GO:2000319 | negative regulation of T-helper 17 type immune response(GO:2000317) regulation of T-helper 17 cell differentiation(GO:2000319) negative regulation of T-helper 17 cell differentiation(GO:2000320) |
| 0.3 | 1.4 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
| 0.3 | 1.7 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
| 0.3 | 4.1 | GO:1902231 | positive regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902231) |
| 0.3 | 0.3 | GO:0060994 | regulation of transcription from RNA polymerase II promoter involved in kidney development(GO:0060994) |
| 0.3 | 1.7 | GO:0030423 | targeting of mRNA for destruction involved in RNA interference(GO:0030423) |
| 0.3 | 1.7 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
| 0.3 | 1.7 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.3 | 2.7 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
| 0.3 | 0.3 | GO:0033122 | regulation of purine nucleotide catabolic process(GO:0033121) negative regulation of purine nucleotide catabolic process(GO:0033122) |
| 0.3 | 1.0 | GO:0046077 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate metabolic process(GO:0009138) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) deoxyribonucleoside diphosphate biosynthetic process(GO:0009189) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
| 0.3 | 0.3 | GO:0046101 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
| 0.3 | 0.3 | GO:2000468 | regulation of peroxidase activity(GO:2000468) |
| 0.3 | 1.3 | GO:0030046 | parallel actin filament bundle assembly(GO:0030046) |
| 0.3 | 1.3 | GO:2000987 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
| 0.3 | 0.7 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
| 0.3 | 1.7 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
| 0.3 | 1.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
| 0.3 | 2.3 | GO:1900016 | negative regulation of cytokine production involved in inflammatory response(GO:1900016) |
| 0.3 | 0.3 | GO:0036324 | vascular endothelial growth factor receptor-2 signaling pathway(GO:0036324) |
| 0.3 | 3.3 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
| 0.3 | 2.7 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
| 0.3 | 2.0 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
| 0.3 | 0.3 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
| 0.3 | 2.6 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
| 0.3 | 1.0 | GO:0045657 | positive regulation of monocyte differentiation(GO:0045657) |
| 0.3 | 3.9 | GO:0007141 | male meiosis I(GO:0007141) |
| 0.3 | 2.0 | GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation(GO:0006616) |
| 0.3 | 9.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
| 0.3 | 0.3 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
| 0.3 | 3.2 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
| 0.3 | 0.9 | GO:0051030 | snRNA transport(GO:0051030) |
| 0.3 | 0.6 | GO:0035617 | stress granule disassembly(GO:0035617) |
| 0.3 | 0.3 | GO:0072075 | metanephric mesenchyme development(GO:0072075) |
| 0.3 | 2.2 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
| 0.3 | 9.7 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.3 | 0.3 | GO:0006097 | glyoxylate cycle(GO:0006097) |
| 0.3 | 1.9 | GO:0035067 | negative regulation of histone acetylation(GO:0035067) |
| 0.3 | 8.7 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.3 | 2.5 | GO:0000056 | ribosomal small subunit export from nucleus(GO:0000056) |
| 0.3 | 3.7 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
| 0.3 | 0.3 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
| 0.3 | 1.9 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
| 0.3 | 1.5 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
| 0.3 | 0.6 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
| 0.3 | 1.2 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
| 0.3 | 0.9 | GO:0072734 | response to staurosporine(GO:0072733) cellular response to staurosporine(GO:0072734) |
| 0.3 | 1.2 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
| 0.3 | 0.9 | GO:0051305 | chromosome movement towards spindle pole(GO:0051305) |
| 0.3 | 0.3 | GO:0070099 | regulation of chemokine-mediated signaling pathway(GO:0070099) negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
| 0.3 | 3.0 | GO:2000781 | positive regulation of double-strand break repair(GO:2000781) |
| 0.3 | 1.2 | GO:0015888 | thiamine transport(GO:0015888) |
| 0.3 | 1.2 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
| 0.3 | 0.9 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
| 0.3 | 1.5 | GO:0060648 | mammary gland bud morphogenesis(GO:0060648) |
| 0.3 | 0.3 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
| 0.3 | 2.7 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
| 0.3 | 3.0 | GO:1902415 | regulation of mRNA binding(GO:1902415) positive regulation of mRNA binding(GO:1902416) |
| 0.3 | 5.4 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
| 0.3 | 0.6 | GO:0071603 | endothelial cell-cell adhesion(GO:0071603) |
| 0.3 | 3.9 | GO:0046697 | decidualization(GO:0046697) |
| 0.3 | 0.3 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
| 0.3 | 3.9 | GO:0051451 | myoblast migration(GO:0051451) |
| 0.3 | 0.6 | GO:0072014 | proximal tubule development(GO:0072014) |
| 0.3 | 1.8 | GO:0070986 | left/right axis specification(GO:0070986) |
| 0.3 | 1.8 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
| 0.3 | 1.5 | GO:0051661 | maintenance of centrosome location(GO:0051661) |
| 0.3 | 1.2 | GO:0033280 | response to vitamin D(GO:0033280) |
| 0.3 | 1.5 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
| 0.3 | 2.1 | GO:0016114 | terpenoid biosynthetic process(GO:0016114) |
| 0.3 | 0.3 | GO:0032056 | positive regulation of translation in response to stress(GO:0032056) |
| 0.3 | 0.3 | GO:0002901 | mature B cell apoptotic process(GO:0002901) regulation of mature B cell apoptotic process(GO:0002905) negative regulation of mature B cell apoptotic process(GO:0002906) |
| 0.3 | 0.9 | GO:0071047 | nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
| 0.3 | 1.2 | GO:0006344 | maintenance of chromatin silencing(GO:0006344) |
| 0.3 | 0.6 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
| 0.3 | 2.3 | GO:2000489 | hepatic stellate cell activation(GO:0035733) fibroblast activation(GO:0072537) regulation of hepatic stellate cell activation(GO:2000489) |
| 0.3 | 2.0 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) |
| 0.3 | 0.6 | GO:1905203 | regulation of connective tissue replacement(GO:1905203) |
| 0.3 | 0.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
| 0.3 | 0.9 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
| 0.3 | 2.0 | GO:1902165 | regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902165) |
| 0.3 | 0.9 | GO:0090241 | negative regulation of histone H4 acetylation(GO:0090241) |
| 0.3 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
| 0.3 | 0.6 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
| 0.3 | 0.3 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
| 0.3 | 0.9 | GO:0019043 | establishment of viral latency(GO:0019043) |
| 0.3 | 0.3 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
| 0.3 | 3.4 | GO:0031639 | plasminogen activation(GO:0031639) |
| 0.3 | 1.1 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
| 0.3 | 1.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
| 0.3 | 0.6 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
| 0.3 | 0.6 | GO:2000832 | negative regulation of steroid hormone secretion(GO:2000832) |
| 0.3 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.3 | 0.6 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
| 0.3 | 2.8 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
| 0.3 | 0.6 | GO:1903719 | regulation of I-kappaB phosphorylation(GO:1903719) positive regulation of I-kappaB phosphorylation(GO:1903721) |
| 0.3 | 3.3 | GO:1903504 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.3 | 1.4 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.3 | 3.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.3 | 1.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
| 0.3 | 1.1 | GO:0002188 | translation reinitiation(GO:0002188) |
| 0.3 | 3.3 | GO:0000920 | cell separation after cytokinesis(GO:0000920) |
| 0.3 | 0.3 | GO:0000050 | urea cycle(GO:0000050) arginine biosynthetic process(GO:0006526) urea metabolic process(GO:0019627) nitrogen cycle metabolic process(GO:0071941) |
| 0.3 | 1.6 | GO:0032439 | endosome localization(GO:0032439) |
| 0.3 | 1.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
| 0.3 | 5.1 | GO:0045116 | protein neddylation(GO:0045116) |
| 0.3 | 1.1 | GO:0046208 | spermine catabolic process(GO:0046208) |
| 0.3 | 1.1 | GO:0072103 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) |
| 0.3 | 0.8 | GO:0035585 | calcium-mediated signaling using extracellular calcium source(GO:0035585) |
| 0.3 | 0.8 | GO:0046133 | pyrimidine ribonucleoside catabolic process(GO:0046133) |
| 0.3 | 0.5 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) |
| 0.3 | 0.8 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
| 0.3 | 1.3 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
| 0.3 | 2.4 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.3 | 11.1 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
| 0.3 | 0.5 | GO:0000720 | pyrimidine dimer repair by nucleotide-excision repair(GO:0000720) |
| 0.3 | 1.6 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.3 | 2.4 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
| 0.3 | 0.3 | GO:0002295 | T-helper cell lineage commitment(GO:0002295) |
| 0.3 | 2.3 | GO:2000394 | positive regulation of lamellipodium morphogenesis(GO:2000394) |
| 0.3 | 0.8 | GO:0046462 | monoacylglycerol metabolic process(GO:0046462) |
| 0.3 | 1.6 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
| 0.3 | 1.0 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) |
| 0.3 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
| 0.3 | 2.3 | GO:0036344 | platelet morphogenesis(GO:0036344) |
| 0.3 | 0.5 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
| 0.3 | 0.8 | GO:0042264 | peptidyl-aspartic acid hydroxylation(GO:0042264) |
| 0.3 | 1.3 | GO:0002536 | respiratory burst involved in inflammatory response(GO:0002536) |
| 0.3 | 0.3 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
| 0.3 | 3.5 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
| 0.3 | 3.0 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
| 0.3 | 0.5 | GO:0046967 | cytosol to ER transport(GO:0046967) |
| 0.3 | 1.0 | GO:1904672 | regulation of somatic stem cell population maintenance(GO:1904672) |
| 0.3 | 0.8 | GO:0016332 | establishment or maintenance of polarity of embryonic epithelium(GO:0016332) |
| 0.2 | 1.2 | GO:0033140 | negative regulation of peptidyl-serine phosphorylation of STAT protein(GO:0033140) |
| 0.2 | 1.0 | GO:0045903 | positive regulation of translational fidelity(GO:0045903) |
| 0.2 | 0.5 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
| 0.2 | 0.7 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
| 0.2 | 2.5 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
| 0.2 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
| 0.2 | 0.2 | GO:0002363 | alpha-beta T cell lineage commitment(GO:0002363) |
| 0.2 | 0.7 | GO:0098886 | modification of dendritic spine(GO:0098886) |
| 0.2 | 0.5 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
| 0.2 | 1.7 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.2 | 0.2 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
| 0.2 | 0.2 | GO:0050955 | thermoception(GO:0050955) |
| 0.2 | 2.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
| 0.2 | 2.4 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
| 0.2 | 0.7 | GO:0010958 | regulation of amino acid import(GO:0010958) |
| 0.2 | 0.7 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.2 | 2.4 | GO:0006012 | galactose metabolic process(GO:0006012) |
| 0.2 | 0.7 | GO:0070476 | rRNA (guanine-N7)-methylation(GO:0070476) |
| 0.2 | 0.2 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
| 0.2 | 0.2 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
| 0.2 | 0.5 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
| 0.2 | 0.5 | GO:0008063 | Toll signaling pathway(GO:0008063) |
| 0.2 | 0.2 | GO:1990379 | lipid transport across blood brain barrier(GO:1990379) |
| 0.2 | 1.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
| 0.2 | 2.1 | GO:0030049 | muscle filament sliding(GO:0030049) |
| 0.2 | 9.0 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.2 | 0.5 | GO:0042219 | cellular modified amino acid catabolic process(GO:0042219) |
| 0.2 | 0.2 | GO:2000646 | negative regulation of PERK-mediated unfolded protein response(GO:1903898) positive regulation of receptor catabolic process(GO:2000646) |
| 0.2 | 1.9 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
| 0.2 | 0.5 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
| 0.2 | 0.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
| 0.2 | 1.4 | GO:0016321 | female meiosis chromosome segregation(GO:0016321) |
| 0.2 | 0.9 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
| 0.2 | 0.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
| 0.2 | 0.5 | GO:0015675 | nickel cation transport(GO:0015675) |
| 0.2 | 4.6 | GO:0007614 | short-term memory(GO:0007614) |
| 0.2 | 1.1 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
| 0.2 | 0.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
| 0.2 | 0.7 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
| 0.2 | 0.9 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
| 0.2 | 0.2 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
| 0.2 | 0.2 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
| 0.2 | 1.1 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
| 0.2 | 0.5 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
| 0.2 | 0.9 | GO:1904565 | response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904565) cellular response to 1-oleoyl-sn-glycerol 3-phosphate(GO:1904566) |
| 0.2 | 2.7 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
| 0.2 | 1.1 | GO:0051665 | membrane raft localization(GO:0051665) |
| 0.2 | 0.4 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
| 0.2 | 0.9 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
| 0.2 | 1.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
| 0.2 | 1.6 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
| 0.2 | 0.7 | GO:0080184 | response to stilbenoid(GO:0035634) response to phenylpropanoid(GO:0080184) |
| 0.2 | 1.1 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
| 0.2 | 0.7 | GO:0019236 | response to pheromone(GO:0019236) |
| 0.2 | 1.5 | GO:0003177 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
| 0.2 | 0.2 | GO:0071600 | otic vesicle morphogenesis(GO:0071600) |
| 0.2 | 0.7 | GO:0008612 | peptidyl-lysine modification to peptidyl-hypusine(GO:0008612) |
| 0.2 | 3.1 | GO:0043403 | skeletal muscle tissue regeneration(GO:0043403) |
| 0.2 | 0.2 | GO:0072592 | oxygen metabolic process(GO:0072592) |
| 0.2 | 0.7 | GO:0036233 | glycine import(GO:0036233) |
| 0.2 | 0.6 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
| 0.2 | 0.4 | GO:0009814 | defense response, incompatible interaction(GO:0009814) |
| 0.2 | 1.5 | GO:0015791 | polyol transport(GO:0015791) |
| 0.2 | 2.4 | GO:1902583 | viral mRNA export from host cell nucleus(GO:0046784) intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
| 0.2 | 0.9 | GO:0032488 | Cdc42 protein signal transduction(GO:0032488) |
| 0.2 | 0.2 | GO:0010957 | negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.2 | 0.6 | GO:0001180 | transcription initiation from RNA polymerase I promoter for nuclear large rRNA transcript(GO:0001180) |
| 0.2 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
| 0.2 | 1.7 | GO:0031424 | keratinization(GO:0031424) |
| 0.2 | 0.2 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
| 0.2 | 1.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
| 0.2 | 0.4 | GO:1902969 | mitotic DNA replication(GO:1902969) |
| 0.2 | 0.8 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
| 0.2 | 3.4 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
| 0.2 | 1.7 | GO:0042984 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
| 0.2 | 1.2 | GO:0045217 | cell-cell junction maintenance(GO:0045217) |
| 0.2 | 0.6 | GO:0097477 | lateral motor column neuron migration(GO:0097477) |
| 0.2 | 0.4 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
| 0.2 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
| 0.2 | 0.4 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
| 0.2 | 0.2 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
| 0.2 | 1.4 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
| 0.2 | 0.6 | GO:0015960 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
| 0.2 | 0.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
| 0.2 | 0.8 | GO:2001032 | regulation of double-strand break repair via nonhomologous end joining(GO:2001032) |
| 0.2 | 1.0 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
| 0.2 | 2.9 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) |
| 0.2 | 0.2 | GO:0097212 | lysosomal membrane organization(GO:0097212) |
| 0.2 | 0.6 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
| 0.2 | 0.6 | GO:0006624 | vacuolar protein processing(GO:0006624) |
| 0.2 | 1.4 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
| 0.2 | 1.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
| 0.2 | 0.6 | GO:0001887 | selenium compound metabolic process(GO:0001887) selenocysteine metabolic process(GO:0016259) |
| 0.2 | 3.4 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.2 | 1.0 | GO:0090195 | chemokine secretion(GO:0090195) regulation of chemokine secretion(GO:0090196) positive regulation of chemokine secretion(GO:0090197) |
| 0.2 | 1.6 | GO:0051490 | negative regulation of filopodium assembly(GO:0051490) |
| 0.2 | 0.6 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
| 0.2 | 0.4 | GO:0044837 | assembly of actomyosin apparatus involved in cytokinesis(GO:0000912) actomyosin contractile ring assembly(GO:0000915) actomyosin contractile ring organization(GO:0044837) |
| 0.2 | 0.6 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
| 0.2 | 0.8 | GO:0060155 | platelet dense granule organization(GO:0060155) |
| 0.2 | 2.6 | GO:0042407 | cristae formation(GO:0042407) |
| 0.2 | 9.9 | GO:0006749 | glutathione metabolic process(GO:0006749) |
| 0.2 | 1.2 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
| 0.2 | 0.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
| 0.2 | 0.4 | GO:0006507 | GPI anchor release(GO:0006507) |
| 0.2 | 1.6 | GO:0045109 | intermediate filament organization(GO:0045109) |
| 0.2 | 2.3 | GO:0032986 | protein-DNA complex disassembly(GO:0032986) |
| 0.2 | 1.2 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.2 | 1.9 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
| 0.2 | 0.6 | GO:1904874 | positive regulation of telomerase RNA localization to Cajal body(GO:1904874) |
| 0.2 | 0.4 | GO:0090343 | positive regulation of cell aging(GO:0090343) |
| 0.2 | 0.6 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
| 0.2 | 0.4 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
| 0.2 | 1.3 | GO:0090201 | negative regulation of release of cytochrome c from mitochondria(GO:0090201) |
| 0.2 | 0.6 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.2 | 0.4 | GO:0072382 | minus-end-directed vesicle transport along microtubule(GO:0072382) |
| 0.2 | 3.0 | GO:0007080 | mitotic metaphase plate congression(GO:0007080) |
| 0.2 | 2.5 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
| 0.2 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
| 0.2 | 0.8 | GO:0046036 | CTP biosynthetic process(GO:0006241) CTP metabolic process(GO:0046036) |
| 0.2 | 0.9 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
| 0.2 | 0.4 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
| 0.2 | 0.9 | GO:0036499 | PERK-mediated unfolded protein response(GO:0036499) |
| 0.2 | 0.6 | GO:0071107 | response to parathyroid hormone(GO:0071107) |
| 0.2 | 0.9 | GO:0000054 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
| 0.2 | 3.2 | GO:0050909 | sensory perception of taste(GO:0050909) |
| 0.2 | 0.6 | GO:1902310 | positive regulation of peptidyl-serine dephosphorylation(GO:1902310) |
| 0.2 | 0.2 | GO:0031133 | regulation of axon diameter(GO:0031133) |
| 0.2 | 1.9 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
| 0.2 | 0.4 | GO:2001184 | regulation of interleukin-12 secretion(GO:2001182) positive regulation of interleukin-12 secretion(GO:2001184) |
| 0.2 | 0.2 | GO:0016128 | phytosteroid metabolic process(GO:0016128) phytosteroid biosynthetic process(GO:0016129) |
| 0.2 | 0.9 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
| 0.2 | 0.4 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
| 0.2 | 3.7 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.2 | 0.9 | GO:0051697 | protein delipidation(GO:0051697) |
| 0.2 | 0.4 | GO:0045002 | double-strand break repair via single-strand annealing(GO:0045002) |
| 0.2 | 0.2 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
| 0.2 | 0.4 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.2 | 4.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
| 0.2 | 0.2 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
| 0.2 | 0.9 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
| 0.2 | 0.2 | GO:0030656 | regulation of vitamin metabolic process(GO:0030656) |
| 0.2 | 0.4 | GO:0060830 | ciliary receptor clustering involved in smoothened signaling pathway(GO:0060830) |
| 0.2 | 0.9 | GO:0006543 | glutamine catabolic process(GO:0006543) |
| 0.2 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 0.7 | GO:0031017 | exocrine pancreas development(GO:0031017) |
| 0.2 | 0.4 | GO:1903538 | meiotic cell cycle process involved in oocyte maturation(GO:1903537) regulation of meiotic cell cycle process involved in oocyte maturation(GO:1903538) |
| 0.2 | 0.7 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
| 0.2 | 0.7 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
| 0.2 | 7.1 | GO:0035690 | cellular response to drug(GO:0035690) |
| 0.2 | 0.5 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
| 0.2 | 0.2 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
| 0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
| 0.2 | 9.2 | GO:0002181 | cytoplasmic translation(GO:0002181) |
| 0.2 | 0.4 | GO:1903416 | response to glycoside(GO:1903416) |
| 0.2 | 0.4 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
| 0.2 | 0.2 | GO:0051582 | positive regulation of synaptic transmission, dopaminergic(GO:0032226) positive regulation of neurotransmitter uptake(GO:0051582) regulation of dopamine uptake involved in synaptic transmission(GO:0051584) positive regulation of dopamine uptake involved in synaptic transmission(GO:0051586) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) positive regulation of catecholamine uptake involved in synaptic transmission(GO:0051944) |
| 0.2 | 2.2 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
| 0.2 | 6.3 | GO:0043044 | ATP-dependent chromatin remodeling(GO:0043044) |
| 0.2 | 0.9 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.2 | 0.2 | GO:0061744 | motor behavior(GO:0061744) |
| 0.2 | 8.8 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.2 | 0.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
| 0.2 | 0.5 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
| 0.2 | 0.9 | GO:0032796 | uropod organization(GO:0032796) |
| 0.2 | 0.7 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) positive regulation of translational initiation by iron(GO:0045994) angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
| 0.2 | 1.1 | GO:0060231 | mesenchymal to epithelial transition(GO:0060231) |
| 0.2 | 0.2 | GO:0045019 | negative regulation of nitric oxide biosynthetic process(GO:0045019) negative regulation of nitric oxide metabolic process(GO:1904406) |
| 0.2 | 0.7 | GO:0001661 | conditioned taste aversion(GO:0001661) |
| 0.2 | 0.4 | GO:1904529 | regulation of actin filament binding(GO:1904529) regulation of actin binding(GO:1904616) |
| 0.2 | 0.4 | GO:0035814 | negative regulation of renal sodium excretion(GO:0035814) |
| 0.2 | 0.4 | GO:0030222 | eosinophil differentiation(GO:0030222) |
| 0.2 | 2.3 | GO:0016486 | peptide hormone processing(GO:0016486) |
| 0.2 | 2.3 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.2 | 0.9 | GO:0060179 | male mating behavior(GO:0060179) |
| 0.2 | 0.5 | GO:1904355 | positive regulation of telomere capping(GO:1904355) |
| 0.2 | 5.1 | GO:0000462 | maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000462) |
| 0.2 | 1.4 | GO:0046085 | adenosine metabolic process(GO:0046085) |
| 0.2 | 0.5 | GO:0046060 | dATP metabolic process(GO:0046060) |
| 0.2 | 0.2 | GO:1905050 | positive regulation of metallopeptidase activity(GO:1905050) |
| 0.2 | 0.5 | GO:0097089 | methyl-branched fatty acid metabolic process(GO:0097089) |
| 0.2 | 0.3 | GO:0071455 | response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
| 0.2 | 0.3 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
| 0.2 | 0.9 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.2 | 0.7 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
| 0.2 | 3.1 | GO:0040034 | regulation of development, heterochronic(GO:0040034) |
| 0.2 | 0.7 | GO:1900533 | medium-chain fatty-acyl-CoA catabolic process(GO:0036114) long-chain fatty-acyl-CoA catabolic process(GO:0036116) palmitic acid metabolic process(GO:1900533) palmitic acid biosynthetic process(GO:1900535) |
| 0.2 | 0.7 | GO:1990022 | RNA polymerase II complex import to nucleus(GO:0044376) RNA polymerase III complex localization to nucleus(GO:1990022) |
| 0.2 | 3.1 | GO:0019835 | cytolysis(GO:0019835) |
| 0.2 | 0.7 | GO:0051866 | general adaptation syndrome(GO:0051866) |
| 0.2 | 1.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
| 0.2 | 0.7 | GO:0050862 | positive regulation of T cell receptor signaling pathway(GO:0050862) |
| 0.2 | 0.9 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
| 0.2 | 0.8 | GO:2000325 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
| 0.2 | 0.5 | GO:0098706 | ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
| 0.2 | 1.3 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.2 | 0.2 | GO:0061055 | myotome development(GO:0061055) |
| 0.2 | 0.5 | GO:0007398 | ectoderm development(GO:0007398) |
| 0.2 | 2.3 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 2.5 | GO:0006465 | signal peptide processing(GO:0006465) |
| 0.2 | 0.5 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
| 0.2 | 0.3 | GO:0070633 | transepithelial transport(GO:0070633) |
| 0.2 | 0.5 | GO:0060428 | lung epithelium development(GO:0060428) |
| 0.2 | 1.8 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
| 0.2 | 1.8 | GO:0035115 | embryonic forelimb morphogenesis(GO:0035115) |
| 0.2 | 1.0 | GO:0044241 | lipid digestion(GO:0044241) |
| 0.2 | 0.7 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.2 | 0.7 | GO:0006706 | steroid catabolic process(GO:0006706) |
| 0.2 | 0.5 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
| 0.2 | 1.0 | GO:0034214 | protein hexamerization(GO:0034214) |
| 0.2 | 0.3 | GO:0006528 | asparagine metabolic process(GO:0006528) |
| 0.2 | 7.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.2 | 0.3 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
| 0.2 | 1.3 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.2 | 0.3 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
| 0.2 | 0.2 | GO:0036093 | germ cell proliferation(GO:0036093) |
| 0.2 | 0.3 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
| 0.2 | 0.2 | GO:0097350 | neutrophil clearance(GO:0097350) |
| 0.2 | 1.6 | GO:0060707 | trophoblast giant cell differentiation(GO:0060707) |
| 0.2 | 6.0 | GO:0045454 | cell redox homeostasis(GO:0045454) |
| 0.2 | 1.6 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
| 0.2 | 0.6 | GO:1903764 | regulation of potassium ion export(GO:1902302) regulation of potassium ion export across plasma membrane(GO:1903764) |
| 0.2 | 3.9 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.2 | 2.4 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.2 | 0.3 | GO:0072697 | protein localization to cell cortex(GO:0072697) |
| 0.2 | 0.6 | GO:0050855 | regulation of B cell receptor signaling pathway(GO:0050855) positive regulation of B cell receptor signaling pathway(GO:0050861) |
| 0.2 | 1.0 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
| 0.2 | 0.6 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
| 0.2 | 1.4 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
| 0.2 | 0.6 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
| 0.2 | 1.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 | 0.5 | GO:0014866 | skeletal myofibril assembly(GO:0014866) |
| 0.2 | 0.5 | GO:0060056 | mammary gland involution(GO:0060056) |
| 0.2 | 8.5 | GO:0009142 | nucleoside triphosphate biosynthetic process(GO:0009142) |
| 0.2 | 0.2 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
| 0.2 | 0.9 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
| 0.2 | 0.9 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
| 0.2 | 0.6 | GO:0097152 | mesenchymal cell apoptotic process(GO:0097152) |
| 0.2 | 0.5 | GO:0051353 | positive regulation of oxidoreductase activity(GO:0051353) |
| 0.2 | 0.6 | GO:1903031 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
| 0.2 | 1.4 | GO:0034308 | primary alcohol metabolic process(GO:0034308) |
| 0.2 | 2.0 | GO:0030490 | maturation of SSU-rRNA(GO:0030490) |
| 0.2 | 0.2 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
| 0.2 | 0.2 | GO:0061042 | vascular wound healing(GO:0061042) |
| 0.1 | 0.1 | GO:0034637 | cellular carbohydrate biosynthetic process(GO:0034637) |
| 0.1 | 0.9 | GO:0097646 | calcitonin family receptor signaling pathway(GO:0097646) amylin receptor signaling pathway(GO:0097647) |
| 0.1 | 2.4 | GO:0001569 | patterning of blood vessels(GO:0001569) |
| 0.1 | 1.0 | GO:0036296 | response to increased oxygen levels(GO:0036296) |
| 0.1 | 0.7 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
| 0.1 | 0.1 | GO:0046037 | GMP metabolic process(GO:0046037) |
| 0.1 | 0.6 | GO:0006824 | cobalt ion transport(GO:0006824) |
| 0.1 | 0.6 | GO:0046909 | intermembrane transport(GO:0046909) protein transport from ciliary membrane to plasma membrane(GO:1903445) |
| 0.1 | 0.7 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
| 0.1 | 1.3 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
| 0.1 | 0.6 | GO:0051798 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.1 | 1.6 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 | 0.3 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
| 0.1 | 0.1 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
| 0.1 | 0.4 | GO:0048599 | oocyte development(GO:0048599) |
| 0.1 | 1.1 | GO:0097286 | iron ion import(GO:0097286) |
| 0.1 | 0.3 | GO:0001990 | regulation of systemic arterial blood pressure by hormone(GO:0001990) |
| 0.1 | 0.1 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
| 0.1 | 0.6 | GO:0072675 | osteoclast fusion(GO:0072675) |
| 0.1 | 1.3 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
| 0.1 | 0.3 | GO:0071499 | response to laminar fluid shear stress(GO:0034616) cellular response to laminar fluid shear stress(GO:0071499) |
| 0.1 | 0.3 | GO:0051316 | attachment of spindle microtubules to kinetochore involved in meiotic chromosome segregation(GO:0051316) |
| 0.1 | 1.1 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
| 0.1 | 0.4 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
| 0.1 | 0.1 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
| 0.1 | 3.6 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.1 | 0.1 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
| 0.1 | 0.6 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
| 0.1 | 0.6 | GO:0006421 | asparaginyl-tRNA aminoacylation(GO:0006421) |
| 0.1 | 1.5 | GO:0007530 | sex determination(GO:0007530) |
| 0.1 | 2.1 | GO:0051351 | positive regulation of ligase activity(GO:0051351) |
| 0.1 | 0.1 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
| 0.1 | 0.1 | GO:0072498 | embryonic skeletal joint development(GO:0072498) |
| 0.1 | 0.5 | GO:0002143 | tRNA wobble position uridine thiolation(GO:0002143) |
| 0.1 | 5.7 | GO:0006505 | GPI anchor metabolic process(GO:0006505) GPI anchor biosynthetic process(GO:0006506) |
| 0.1 | 0.5 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.1 | 0.3 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
| 0.1 | 0.4 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
| 0.1 | 0.4 | GO:0000429 | carbon catabolite regulation of transcription from RNA polymerase II promoter(GO:0000429) carbon catabolite activation of transcription from RNA polymerase II promoter(GO:0000436) carbon catabolite regulation of transcription(GO:0045990) carbon catabolite activation of transcription(GO:0045991) |
| 0.1 | 0.1 | GO:0060956 | endocardial cell differentiation(GO:0060956) |
| 0.1 | 0.7 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
| 0.1 | 0.7 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
| 0.1 | 0.3 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
| 0.1 | 2.0 | GO:1902807 | negative regulation of cell cycle G1/S phase transition(GO:1902807) |
| 0.1 | 1.1 | GO:0034244 | negative regulation of transcription elongation from RNA polymerase II promoter(GO:0034244) |
| 0.1 | 0.3 | GO:0046015 | regulation of transcription by glucose(GO:0046015) |
| 0.1 | 0.3 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
| 0.1 | 0.4 | GO:0039702 | viral budding via host ESCRT complex(GO:0039702) |
| 0.1 | 0.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
| 0.1 | 0.3 | GO:0097278 | complement-dependent cytotoxicity(GO:0097278) |
| 0.1 | 0.5 | GO:0046210 | nitrate catabolic process(GO:0043602) nitric oxide catabolic process(GO:0046210) cellular organohalogen metabolic process(GO:0090345) cellular organofluorine metabolic process(GO:0090346) |
| 0.1 | 0.5 | GO:0018195 | peptidyl-arginine modification(GO:0018195) |
| 0.1 | 0.4 | GO:0034035 | sulfate assimilation(GO:0000103) purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 | 1.2 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.1 | 1.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.1 | 1.4 | GO:1901250 | regulation of lung goblet cell differentiation(GO:1901249) negative regulation of lung goblet cell differentiation(GO:1901250) |
| 0.1 | 0.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
| 0.1 | 0.4 | GO:0006788 | heme oxidation(GO:0006788) |
| 0.1 | 0.9 | GO:0010826 | negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 | 0.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.1 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
| 0.1 | 0.6 | GO:0034587 | piRNA metabolic process(GO:0034587) |
| 0.1 | 0.3 | GO:0051712 | positive regulation of killing of cells of other organism(GO:0051712) |
| 0.1 | 0.4 | GO:0046900 | tetrahydrofolylpolyglutamate metabolic process(GO:0046900) |
| 0.1 | 0.5 | GO:0045607 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
| 0.1 | 1.0 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
| 0.1 | 0.1 | GO:0008214 | protein demethylation(GO:0006482) protein dealkylation(GO:0008214) |
| 0.1 | 0.3 | GO:2000834 | androgen secretion(GO:0035935) testosterone secretion(GO:0035936) negative regulation of glucagon secretion(GO:0070093) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) regulation of testosterone secretion(GO:2000843) positive regulation of testosterone secretion(GO:2000845) |
| 0.1 | 0.4 | GO:0060010 | Sertoli cell fate commitment(GO:0060010) |
| 0.1 | 0.1 | GO:0032417 | positive regulation of sodium:proton antiporter activity(GO:0032417) |
| 0.1 | 1.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.1 | 0.1 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
| 0.1 | 0.6 | GO:1901724 | positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.1 | 0.6 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
| 0.1 | 0.1 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
| 0.1 | 0.6 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 0.7 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
| 0.1 | 0.4 | GO:1900060 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) negative regulation of ceramide biosynthetic process(GO:1900060) |
| 0.1 | 1.4 | GO:0035987 | endodermal cell differentiation(GO:0035987) |
| 0.1 | 0.6 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
| 0.1 | 0.9 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
| 0.1 | 0.4 | GO:0060011 | Sertoli cell proliferation(GO:0060011) |
| 0.1 | 0.1 | GO:0014016 | neuroblast differentiation(GO:0014016) |
| 0.1 | 0.4 | GO:0042126 | nitrate metabolic process(GO:0042126) |
| 0.1 | 0.4 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 | 0.5 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
| 0.1 | 0.1 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
| 0.1 | 1.3 | GO:0001937 | negative regulation of endothelial cell proliferation(GO:0001937) |
| 0.1 | 3.9 | GO:0006284 | base-excision repair(GO:0006284) |
| 0.1 | 0.1 | GO:1903012 | positive regulation of bone development(GO:1903012) |
| 0.1 | 1.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
| 0.1 | 0.1 | GO:0032829 | regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032829) |
| 0.1 | 0.9 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.1 | 0.8 | GO:1903298 | regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903297) negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway(GO:1903298) |
| 0.1 | 1.2 | GO:0046512 | sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.1 | 0.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
| 0.1 | 0.8 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 | 0.1 | GO:0042228 | interleukin-8 biosynthetic process(GO:0042228) regulation of interleukin-8 biosynthetic process(GO:0045414) |
| 0.1 | 0.6 | GO:0032463 | regulation of protein homooligomerization(GO:0032462) negative regulation of protein homooligomerization(GO:0032463) |
| 0.1 | 0.3 | GO:0070836 | caveola assembly(GO:0070836) |
| 0.1 | 0.2 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
| 0.1 | 0.5 | GO:0060290 | transdifferentiation(GO:0060290) |
| 0.1 | 0.2 | GO:0042659 | regulation of cell fate specification(GO:0042659) |
| 0.1 | 0.1 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) cardiac muscle tissue growth involved in heart morphogenesis(GO:0003245) |
| 0.1 | 0.6 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
| 0.1 | 0.9 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
| 0.1 | 0.6 | GO:0046471 | phosphatidylglycerol metabolic process(GO:0046471) |
| 0.1 | 1.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
| 0.1 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
| 0.1 | 0.3 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
| 0.1 | 1.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
| 0.1 | 0.3 | GO:0046794 | transport of virus(GO:0046794) |
| 0.1 | 1.0 | GO:0001682 | tRNA 5'-leader removal(GO:0001682) |
| 0.1 | 0.3 | GO:0090070 | positive regulation of ribosome biogenesis(GO:0090070) positive regulation of rRNA processing(GO:2000234) |
| 0.1 | 0.6 | GO:0044806 | G-quadruplex DNA unwinding(GO:0044806) |
| 0.1 | 0.1 | GO:1904809 | dense core granule localization(GO:0032253) dense core granule transport(GO:1901950) regulation of dense core granule transport(GO:1904809) positive regulation of dense core granule transport(GO:1904811) |
| 0.1 | 1.3 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
| 0.1 | 0.4 | GO:0016560 | protein import into peroxisome matrix, docking(GO:0016560) |
| 0.1 | 0.2 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.1 | 0.7 | GO:0051310 | metaphase plate congression(GO:0051310) |
| 0.1 | 0.4 | GO:0035022 | positive regulation of Rac protein signal transduction(GO:0035022) |
| 0.1 | 0.7 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
| 0.1 | 0.7 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
| 0.1 | 0.7 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
| 0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
| 0.1 | 0.3 | GO:0002082 | regulation of oxidative phosphorylation(GO:0002082) |
| 0.1 | 0.7 | GO:0060539 | diaphragm development(GO:0060539) |
| 0.1 | 0.3 | GO:2001160 | regulation of histone H3-K79 methylation(GO:2001160) |
| 0.1 | 1.0 | GO:0018126 | protein hydroxylation(GO:0018126) |
| 0.1 | 0.1 | GO:0030214 | hyaluronan catabolic process(GO:0030214) |
| 0.1 | 0.4 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
| 0.1 | 0.5 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
| 0.1 | 0.4 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
| 0.1 | 0.7 | GO:0070886 | positive regulation of calcineurin-NFAT signaling cascade(GO:0070886) |
| 0.1 | 0.4 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
| 0.1 | 0.4 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
| 0.1 | 1.2 | GO:0046855 | inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 | 3.1 | GO:0095500 | acetylcholine receptor signaling pathway(GO:0095500) signal transduction involved in cellular response to ammonium ion(GO:1903831) response to acetylcholine(GO:1905144) cellular response to acetylcholine(GO:1905145) |
| 0.1 | 1.5 | GO:0003016 | respiratory system process(GO:0003016) |
| 0.1 | 0.9 | GO:2000381 | negative regulation of mesoderm development(GO:2000381) |
| 0.1 | 0.4 | GO:0048853 | forebrain morphogenesis(GO:0048853) |
| 0.1 | 0.2 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
| 0.1 | 0.1 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
| 0.1 | 0.9 | GO:0006301 | postreplication repair(GO:0006301) |
| 0.1 | 1.8 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
| 0.1 | 0.1 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
| 0.1 | 0.7 | GO:1900262 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
| 0.1 | 0.6 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
| 0.1 | 0.3 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
| 0.1 | 1.0 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
| 0.1 | 0.6 | GO:0071494 | cellular response to UV-C(GO:0071494) |
| 0.1 | 2.0 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
| 0.1 | 0.6 | GO:0071787 | endoplasmic reticulum tubular network assembly(GO:0071787) |
| 0.1 | 0.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 | 0.3 | GO:0046719 | regulation by virus of viral protein levels in host cell(GO:0046719) positive regulation by virus of viral protein levels in host cell(GO:0046726) |
| 0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
| 0.1 | 0.4 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
| 0.1 | 1.1 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.1 | GO:0002710 | negative regulation of T cell mediated immunity(GO:0002710) |
| 0.1 | 0.5 | GO:0010835 | regulation of protein ADP-ribosylation(GO:0010835) |
| 0.1 | 0.9 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.1 | 0.3 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
| 0.1 | 0.1 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
| 0.1 | 1.2 | GO:0042775 | mitochondrial ATP synthesis coupled electron transport(GO:0042775) |
| 0.1 | 1.9 | GO:0002053 | positive regulation of mesenchymal cell proliferation(GO:0002053) |
| 0.1 | 0.2 | GO:0035728 | response to hepatocyte growth factor(GO:0035728) |
| 0.1 | 0.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
| 0.1 | 0.3 | GO:0051923 | sulfation(GO:0051923) |
| 0.1 | 0.7 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
| 0.1 | 0.5 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.1 | 4.6 | GO:0032543 | mitochondrial translation(GO:0032543) |
| 0.1 | 0.1 | GO:0002251 | organ or tissue specific immune response(GO:0002251) |
| 0.1 | 0.2 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
| 0.1 | 1.6 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.1 | 0.6 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.1 | 0.2 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) |
| 0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
| 0.1 | 0.1 | GO:0055099 | response to high density lipoprotein particle(GO:0055099) |
| 0.1 | 0.2 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
| 0.1 | 1.3 | GO:0001936 | regulation of endothelial cell proliferation(GO:0001936) |
| 0.1 | 2.0 | GO:0007566 | embryo implantation(GO:0007566) |
| 0.1 | 0.5 | GO:0021884 | forebrain neuron development(GO:0021884) |
| 0.1 | 0.3 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.1 | 1.2 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.5 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
| 0.1 | 0.4 | GO:1903232 | melanosome assembly(GO:1903232) |
| 0.1 | 0.2 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
| 0.1 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) |
| 0.1 | 0.1 | GO:2000049 | positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
| 0.1 | 0.1 | GO:0070508 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
| 0.1 | 0.2 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
| 0.1 | 0.8 | GO:0006362 | transcription elongation from RNA polymerase I promoter(GO:0006362) |
| 0.1 | 1.2 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
| 0.1 | 0.2 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) regulation of interleukin-6 biosynthetic process(GO:0045408) |
| 0.1 | 0.3 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
| 0.1 | 0.6 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.1 | 0.5 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 0.1 | 0.7 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 | 0.1 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
| 0.1 | 0.3 | GO:0002940 | tRNA N2-guanine methylation(GO:0002940) |
| 0.1 | 0.6 | GO:0070670 | response to interleukin-4(GO:0070670) |
| 0.1 | 0.2 | GO:0001955 | blood vessel maturation(GO:0001955) |
| 0.1 | 0.6 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
| 0.1 | 0.5 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
| 0.1 | 0.4 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
| 0.1 | 0.1 | GO:0045575 | basophil activation involved in immune response(GO:0002276) basophil activation(GO:0045575) |
| 0.1 | 0.3 | GO:0072737 | response to diamide(GO:0072737) cellular response to diamide(GO:0072738) |
| 0.1 | 0.3 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
| 0.1 | 1.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
| 0.1 | 0.1 | GO:0090005 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
| 0.1 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
| 0.1 | 0.6 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
| 0.1 | 0.3 | GO:0014883 | regulation of skeletal muscle adaptation(GO:0014733) transition between fast and slow fiber(GO:0014883) skeletal muscle adaptation(GO:0043501) |
| 0.1 | 0.2 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
| 0.1 | 0.2 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
| 0.1 | 1.4 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
| 0.1 | 1.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.1 | 1.4 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
| 0.1 | 0.2 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
| 0.1 | 0.3 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
| 0.1 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
| 0.1 | 0.2 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
| 0.1 | 0.9 | GO:0000052 | citrulline metabolic process(GO:0000052) |
| 0.1 | 0.6 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.1 | 0.3 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
| 0.1 | 0.3 | GO:0098968 | cochlear nucleus development(GO:0021747) neurotransmitter receptor transport postsynaptic membrane to endosome(GO:0098968) |
| 0.1 | 0.1 | GO:0002339 | B cell selection(GO:0002339) |
| 0.1 | 0.1 | GO:0071963 | establishment or maintenance of cell polarity regulating cell shape(GO:0071963) |
| 0.1 | 0.3 | GO:0021914 | negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning(GO:0021914) |
| 0.1 | 0.3 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
| 0.1 | 0.2 | GO:0030208 | dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.4 | GO:0016198 | axon choice point recognition(GO:0016198) |
| 0.1 | 6.4 | GO:0006364 | rRNA processing(GO:0006364) |
| 0.1 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.2 | GO:0016598 | protein arginylation(GO:0016598) |
| 0.1 | 0.7 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
| 0.1 | 0.3 | GO:0042534 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
| 0.1 | 0.3 | GO:0072318 | clathrin coat disassembly(GO:0072318) |
| 0.1 | 1.4 | GO:0003301 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
| 0.1 | 0.2 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
| 0.1 | 0.2 | GO:0017004 | cytochrome complex assembly(GO:0017004) |
| 0.1 | 0.2 | GO:2000279 | negative regulation of DNA biosynthetic process(GO:2000279) |
| 0.1 | 0.2 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
| 0.1 | 0.2 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
| 0.1 | 0.2 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 0.9 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 | 0.2 | GO:0007084 | mitotic nuclear envelope reassembly(GO:0007084) |
| 0.1 | 0.9 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.1 | 0.4 | GO:0043570 | maintenance of DNA repeat elements(GO:0043570) |
| 0.1 | 0.2 | GO:0039532 | negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway(GO:0039532) |
| 0.1 | 0.2 | GO:0042832 | defense response to protozoan(GO:0042832) |
| 0.1 | 0.3 | GO:0003159 | morphogenesis of an endothelium(GO:0003159) |
| 0.1 | 5.4 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.1 | 0.1 | GO:0060596 | mammary placode formation(GO:0060596) |
| 0.1 | 0.7 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 0.2 | GO:0019348 | dolichol metabolic process(GO:0019348) |
| 0.1 | 0.5 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
| 0.1 | 0.3 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
| 0.1 | 0.4 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
| 0.1 | 2.2 | GO:0008156 | negative regulation of DNA replication(GO:0008156) |
| 0.1 | 5.1 | GO:0006413 | translational initiation(GO:0006413) |
| 0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
| 0.1 | 1.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
| 0.1 | 0.4 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
| 0.1 | 0.7 | GO:0042273 | ribosomal large subunit biogenesis(GO:0042273) |
| 0.1 | 0.5 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
| 0.1 | 0.3 | GO:0046622 | positive regulation of organ growth(GO:0046622) |
| 0.1 | 1.0 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
| 0.1 | 2.4 | GO:0009060 | aerobic respiration(GO:0009060) |
| 0.1 | 0.3 | GO:2001267 | regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001267) |
| 0.1 | 0.5 | GO:0006921 | cellular component disassembly involved in execution phase of apoptosis(GO:0006921) |
| 0.1 | 0.4 | GO:0016576 | histone dephosphorylation(GO:0016576) |
| 0.1 | 0.3 | GO:0005980 | polysaccharide catabolic process(GO:0000272) glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
| 0.1 | 0.3 | GO:0015868 | purine nucleotide transport(GO:0015865) purine ribonucleotide transport(GO:0015868) |
| 0.1 | 0.2 | GO:0032688 | negative regulation of interferon-beta production(GO:0032688) |
| 0.1 | 0.3 | GO:0006833 | water transport(GO:0006833) |
| 0.1 | 0.8 | GO:0014823 | response to activity(GO:0014823) |
| 0.1 | 1.0 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
| 0.1 | 0.1 | GO:0034698 | response to gonadotropin(GO:0034698) cellular response to gonadotropin stimulus(GO:0071371) |
| 0.1 | 0.9 | GO:0005976 | polysaccharide metabolic process(GO:0005976) |
| 0.1 | 0.7 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
| 0.1 | 0.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
| 0.1 | 0.2 | GO:0006983 | ER overload response(GO:0006983) |
| 0.1 | 0.9 | GO:0051352 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
| 0.1 | 0.7 | GO:0046476 | glycosylceramide biosynthetic process(GO:0046476) |
| 0.1 | 0.3 | GO:0032382 | positive regulation of intracellular lipid transport(GO:0032379) positive regulation of intracellular sterol transport(GO:0032382) positive regulation of intracellular cholesterol transport(GO:0032385) regulation of cholesterol import(GO:0060620) lipid hydroperoxide transport(GO:1901373) positive regulation of cholesterol import(GO:1904109) regulation of sterol import(GO:2000909) positive regulation of sterol import(GO:2000911) |
| 0.1 | 0.5 | GO:0015670 | carbon dioxide transport(GO:0015670) |
| 0.1 | 0.3 | GO:0001935 | endothelial cell proliferation(GO:0001935) |
| 0.1 | 0.4 | GO:0001675 | acrosome assembly(GO:0001675) |
| 0.1 | 0.3 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
| 0.1 | 0.3 | GO:0002553 | histamine production involved in inflammatory response(GO:0002349) histamine secretion involved in inflammatory response(GO:0002441) histamine secretion by mast cell(GO:0002553) |
| 0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
| 0.1 | 0.4 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
| 0.1 | 0.1 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
| 0.1 | 0.1 | GO:0034638 | phosphatidylcholine catabolic process(GO:0034638) |
| 0.1 | 0.6 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.1 | 0.8 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
| 0.1 | 0.5 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
| 0.1 | 0.1 | GO:0015817 | histidine transport(GO:0015817) |
| 0.1 | 0.1 | GO:0043280 | positive regulation of cysteine-type endopeptidase activity involved in apoptotic process(GO:0043280) |
| 0.1 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
| 0.1 | 0.5 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
| 0.1 | 0.1 | GO:0043276 | anoikis(GO:0043276) |
| 0.1 | 0.2 | GO:2001225 | regulation of chloride transport(GO:2001225) |
| 0.1 | 0.3 | GO:0031468 | nuclear envelope reassembly(GO:0031468) |
| 0.1 | 0.3 | GO:0006699 | bile acid biosynthetic process(GO:0006699) |
| 0.1 | 0.2 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
| 0.1 | 0.1 | GO:0060192 | negative regulation of lipase activity(GO:0060192) |
| 0.1 | 0.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
| 0.1 | 0.8 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
| 0.1 | 0.3 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
| 0.1 | 0.4 | GO:0035584 | calcium-mediated signaling using intracellular calcium source(GO:0035584) |
| 0.1 | 0.2 | GO:0071168 | protein localization to chromatin(GO:0071168) |
| 0.1 | 0.2 | GO:0001516 | prostaglandin biosynthetic process(GO:0001516) prostanoid biosynthetic process(GO:0046457) |
| 0.1 | 0.1 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
| 0.1 | 0.2 | GO:1902513 | regulation of organelle transport along microtubule(GO:1902513) |
| 0.1 | 0.2 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
| 0.1 | 0.6 | GO:0070265 | necrotic cell death(GO:0070265) |
| 0.1 | 0.3 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
| 0.1 | 0.1 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
| 0.1 | 0.2 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.1 | 0.2 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
| 0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
| 0.1 | 0.2 | GO:0048669 | collateral sprouting in absence of injury(GO:0048669) |
| 0.1 | 0.3 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
| 0.1 | 0.2 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
| 0.0 | 0.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) |
| 0.0 | 0.1 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.0 | 0.0 | GO:0006878 | cellular copper ion homeostasis(GO:0006878) |
| 0.0 | 0.2 | GO:0042167 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
| 0.0 | 0.1 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
| 0.0 | 0.2 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.0 | 0.1 | GO:0072376 | protein activation cascade(GO:0072376) |
| 0.0 | 0.4 | GO:0015884 | folic acid transport(GO:0015884) |
| 0.0 | 0.2 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
| 0.0 | 0.1 | GO:1904245 | regulation of polynucleotide adenylyltransferase activity(GO:1904245) |
| 0.0 | 0.1 | GO:0034312 | diol biosynthetic process(GO:0034312) |
| 0.0 | 0.8 | GO:0006414 | translational elongation(GO:0006414) |
| 0.0 | 0.0 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
| 0.0 | 0.3 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
| 0.0 | 0.1 | GO:0046370 | fructose biosynthetic process(GO:0046370) |
| 0.0 | 0.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
| 0.0 | 1.4 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
| 0.0 | 0.1 | GO:0006550 | isoleucine catabolic process(GO:0006550) |
| 0.0 | 0.2 | GO:0032366 | intracellular sterol transport(GO:0032366) intracellular cholesterol transport(GO:0032367) |
| 0.0 | 1.5 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.0 | 0.0 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
| 0.0 | 0.4 | GO:1990542 | mitochondrial transmembrane transport(GO:1990542) |
| 0.0 | 0.3 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
| 0.0 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.0 | 0.2 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
| 0.0 | 0.0 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
| 0.0 | 0.5 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.0 | 0.3 | GO:0001765 | membrane raft assembly(GO:0001765) |
| 0.0 | 0.1 | GO:2000192 | negative regulation of fatty acid transport(GO:2000192) |
| 0.0 | 1.2 | GO:0018345 | protein palmitoylation(GO:0018345) |
| 0.0 | 0.1 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
| 0.0 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
| 0.0 | 0.2 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
| 0.0 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
| 0.0 | 0.4 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
| 0.0 | 0.8 | GO:0006399 | tRNA metabolic process(GO:0006399) |
| 0.0 | 0.6 | GO:0099517 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
| 0.0 | 0.6 | GO:0048255 | mRNA stabilization(GO:0048255) |
| 0.0 | 0.1 | GO:0002586 | positive regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002582) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) positive regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002588) detection of peptidoglycan(GO:0032499) |
| 0.0 | 0.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
| 0.0 | 0.4 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
| 0.0 | 0.1 | GO:0006207 | 'de novo' pyrimidine nucleobase biosynthetic process(GO:0006207) pyrimidine nucleobase biosynthetic process(GO:0019856) |
| 0.0 | 1.8 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
| 0.0 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
| 0.0 | 0.1 | GO:0019730 | antimicrobial humoral response(GO:0019730) |
| 0.0 | 1.2 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
| 0.0 | 0.2 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.0 | 0.0 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
| 0.0 | 0.1 | GO:0042246 | tissue regeneration(GO:0042246) |
| 0.0 | 0.1 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.0 | 0.0 | GO:0061013 | regulation of mRNA catabolic process(GO:0061013) positive regulation of mRNA catabolic process(GO:0061014) |
| 0.0 | 0.9 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.0 | 0.1 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.0 | 0.2 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.0 | 0.1 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
| 0.0 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
| 0.0 | 0.1 | GO:0036353 | histone H2A-K119 monoubiquitination(GO:0036353) |
| 0.0 | 1.5 | GO:1904893 | negative regulation of JAK-STAT cascade(GO:0046426) negative regulation of STAT cascade(GO:1904893) |
| 0.0 | 0.5 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.0 | 0.2 | GO:0098734 | protein depalmitoylation(GO:0002084) macromolecule depalmitoylation(GO:0098734) |
| 0.0 | 0.5 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
| 0.0 | 0.1 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.0 | 0.2 | GO:0043249 | erythrocyte maturation(GO:0043249) |
| 0.0 | 0.4 | GO:0008272 | sulfate transport(GO:0008272) |
| 0.0 | 0.3 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.0 | 0.1 | GO:0046368 | GDP-L-fucose metabolic process(GO:0046368) |
| 0.0 | 0.1 | GO:0006760 | folic acid-containing compound metabolic process(GO:0006760) |
| 0.0 | 0.1 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
| 0.0 | 2.7 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
| 0.0 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
| 0.0 | 0.1 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.0 | 0.2 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.0 | 0.1 | GO:1903223 | positive regulation of oxidative stress-induced neuron death(GO:1903223) positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903378) |
| 0.0 | 0.2 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
| 0.0 | 0.1 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) kynurenine metabolic process(GO:0070189) |
| 0.0 | 0.1 | GO:0014809 | regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion(GO:0014809) |
| 0.0 | 0.6 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.0 | 0.2 | GO:0001773 | myeloid dendritic cell activation(GO:0001773) |
| 0.0 | 0.1 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
| 0.0 | 0.1 | GO:1902732 | positive regulation of chondrocyte proliferation(GO:1902732) |
| 0.0 | 0.2 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
| 0.0 | 0.3 | GO:0009312 | oligosaccharide biosynthetic process(GO:0009312) |
| 0.0 | 0.0 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
| 0.0 | 0.2 | GO:1901162 | serotonin biosynthetic process(GO:0042427) indole-containing compound biosynthetic process(GO:0042435) primary amino compound biosynthetic process(GO:1901162) |
| 0.0 | 0.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
| 0.0 | 0.1 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
| 0.0 | 0.4 | GO:0046069 | cGMP catabolic process(GO:0046069) |
| 0.0 | 0.4 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.0 | 0.1 | GO:0043489 | RNA stabilization(GO:0043489) |
| 0.0 | 0.1 | GO:0019389 | glucuronoside metabolic process(GO:0019389) |
| 0.0 | 0.1 | GO:0031340 | positive regulation of vesicle fusion(GO:0031340) |
| 0.0 | 0.1 | GO:0071028 | nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 0.0 | 0.1 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
| 0.0 | 1.8 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
| 0.0 | 0.1 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
| 0.0 | 0.0 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
| 0.0 | 0.0 | GO:0043970 | histone H3-K9 acetylation(GO:0043970) |
| 0.0 | 0.2 | GO:0030953 | astral microtubule organization(GO:0030953) |
| 0.0 | 0.1 | GO:0006283 | transcription-coupled nucleotide-excision repair(GO:0006283) |
| 0.0 | 0.3 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
| 0.0 | 0.1 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) |
| 0.0 | 0.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
| 0.0 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
| 0.0 | 0.3 | GO:0002455 | humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.0 | 0.0 | GO:0009597 | detection of virus(GO:0009597) |
| 0.0 | 0.1 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
| 0.0 | 0.2 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
| 0.0 | 0.0 | GO:0072070 | loop of Henle development(GO:0072070) |
| 0.0 | 0.1 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
| 0.0 | 0.3 | GO:0071466 | cellular response to xenobiotic stimulus(GO:0071466) |
| 0.0 | 0.0 | GO:0098705 | copper ion import across plasma membrane(GO:0098705) copper ion import into cell(GO:1902861) |
| 0.0 | 0.0 | GO:0033045 | regulation of sister chromatid segregation(GO:0033045) |
| 0.0 | 0.1 | GO:0015701 | bicarbonate transport(GO:0015701) |
| 0.0 | 0.2 | GO:0032060 | bleb assembly(GO:0032060) |
| 0.0 | 0.1 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
| 0.0 | 0.1 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
| 0.0 | 0.0 | GO:0000973 | posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000973) |
| 0.0 | 0.1 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
| 0.0 | 0.1 | GO:0002175 | protein localization to paranode region of axon(GO:0002175) |
| 0.0 | 0.1 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.0 | 0.0 | GO:0021933 | radial glia guided migration of cerebellar granule cell(GO:0021933) |
| 0.0 | 0.1 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
| 0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.0 | 0.2 | GO:0010762 | regulation of fibroblast migration(GO:0010762) |
| 0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
| 0.0 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
| 0.0 | 0.1 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
| 0.0 | 0.0 | GO:0006116 | NADH oxidation(GO:0006116) |
| 0.0 | 0.1 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
| 0.0 | 0.1 | GO:0034389 | lipid particle organization(GO:0034389) |
| 0.0 | 0.0 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
| 0.0 | 0.0 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
| 0.0 | 0.0 | GO:0042730 | fibrinolysis(GO:0042730) |
| 0.0 | 0.1 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
| 0.0 | 0.1 | GO:0001980 | regulation of systemic arterial blood pressure by ischemic conditions(GO:0001980) |
| 0.0 | 0.1 | GO:0043312 | neutrophil degranulation(GO:0043312) |
| 0.0 | 0.1 | GO:0060628 | regulation of ER to Golgi vesicle-mediated transport(GO:0060628) |
| 0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous antigen(GO:0019883) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
| 0.0 | 0.0 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K6-linked deubiquitination(GO:0044313) |
| 0.0 | 0.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.0 | 0.1 | GO:0001692 | histamine metabolic process(GO:0001692) |
| 0.0 | 0.6 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 | 2.7 | GO:0000398 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
| 0.0 | 0.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
| 0.0 | 0.2 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
| 0.0 | 0.1 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
| 0.0 | 0.1 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
| 0.0 | 0.1 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
| 0.0 | 0.2 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
| 0.0 | 0.0 | GO:0048208 | vesicle targeting, rough ER to cis-Golgi(GO:0048207) COPII vesicle coating(GO:0048208) |
| 0.0 | 0.1 | GO:0098877 | neurotransmitter receptor transport to plasma membrane(GO:0098877) |
| 0.0 | 0.0 | GO:0070257 | positive regulation of mucus secretion(GO:0070257) |
| 0.0 | 0.0 | GO:0001830 | trophectodermal cell fate commitment(GO:0001830) |
| 0.0 | 0.0 | GO:0040031 | snRNA modification(GO:0040031) |
| 0.0 | 0.0 | GO:0002043 | blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:0002043) |
| 0.0 | 0.1 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.0 | 0.0 | GO:0097105 | presynaptic membrane assembly(GO:0097105) |
| 0.0 | 0.1 | GO:0036506 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
| 0.0 | 0.0 | GO:1904707 | regulation of vascular smooth muscle cell proliferation(GO:1904705) positive regulation of vascular smooth muscle cell proliferation(GO:1904707) vascular smooth muscle cell proliferation(GO:1990874) |
| 0.0 | 0.0 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
| 0.0 | 0.0 | GO:0034382 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
| 0.0 | 0.6 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 | 0.0 | GO:0051458 | corticotropin secretion(GO:0051458) |
| 0.0 | 0.1 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
| 0.0 | 0.2 | GO:0010633 | negative regulation of epithelial cell migration(GO:0010633) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 1.3 | 3.9 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
| 1.2 | 5.0 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
| 1.2 | 3.6 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
| 1.2 | 4.7 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
| 1.1 | 6.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 1.1 | 4.3 | GO:0045098 | type III intermediate filament(GO:0045098) |
| 1.0 | 6.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
| 0.9 | 3.6 | GO:0002111 | BRCA2-BRAF35 complex(GO:0002111) |
| 0.9 | 2.7 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
| 0.8 | 5.6 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
| 0.8 | 2.4 | GO:0043224 | nuclear SCF ubiquitin ligase complex(GO:0043224) |
| 0.8 | 2.3 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
| 0.7 | 2.2 | GO:1990667 | PCSK9-AnxA2 complex(GO:1990667) |
| 0.7 | 2.9 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.7 | 2.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
| 0.7 | 2.1 | GO:0033193 | Lsd1/2 complex(GO:0033193) |
| 0.7 | 7.5 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
| 0.7 | 0.7 | GO:1902737 | dendritic filopodium(GO:1902737) |
| 0.7 | 4.6 | GO:0001740 | Barr body(GO:0001740) |
| 0.6 | 4.4 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
| 0.6 | 3.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.6 | 1.8 | GO:0070557 | PCNA-p21 complex(GO:0070557) |
| 0.6 | 6.7 | GO:0005642 | annulate lamellae(GO:0005642) |
| 0.6 | 4.3 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
| 0.6 | 1.2 | GO:0044299 | C-fiber(GO:0044299) |
| 0.6 | 3.6 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
| 0.6 | 1.8 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
| 0.6 | 3.6 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.6 | 3.6 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.6 | 3.4 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.6 | 1.7 | GO:0000805 | X chromosome(GO:0000805) |
| 0.5 | 4.2 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.5 | 2.6 | GO:1990246 | uniplex complex(GO:1990246) |
| 0.5 | 5.2 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) |
| 0.5 | 2.6 | GO:0005784 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.5 | 3.0 | GO:0097452 | GAIT complex(GO:0097452) |
| 0.5 | 7.0 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
| 0.5 | 1.0 | GO:0014802 | terminal cisterna(GO:0014802) |
| 0.5 | 2.9 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.5 | 1.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
| 0.5 | 1.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
| 0.5 | 1.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
| 0.5 | 1.9 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
| 0.5 | 0.5 | GO:0043256 | laminin complex(GO:0043256) |
| 0.5 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
| 0.5 | 1.8 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
| 0.4 | 1.3 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 0.4 | 4.5 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
| 0.4 | 1.3 | GO:0005588 | collagen type V trimer(GO:0005588) |
| 0.4 | 5.7 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.4 | 1.3 | GO:0000801 | central element(GO:0000801) |
| 0.4 | 0.4 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
| 0.4 | 5.6 | GO:0034663 | endoplasmic reticulum chaperone complex(GO:0034663) |
| 0.4 | 2.1 | GO:0099524 | region of cytosol(GO:0099522) postsynaptic cytosol(GO:0099524) |
| 0.4 | 3.3 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.4 | 1.7 | GO:0032127 | dense core granule membrane(GO:0032127) |
| 0.4 | 7.0 | GO:0000124 | SAGA complex(GO:0000124) |
| 0.4 | 2.8 | GO:0016589 | NURF complex(GO:0016589) |
| 0.4 | 4.7 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.4 | 2.0 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
| 0.4 | 1.6 | GO:0098559 | cytoplasmic side of early endosome membrane(GO:0098559) |
| 0.4 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) spherical high-density lipoprotein particle(GO:0034366) |
| 0.4 | 2.7 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.4 | 3.4 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
| 0.4 | 1.1 | GO:0005673 | transcription factor TFIIE complex(GO:0005673) |
| 0.4 | 1.1 | GO:0044194 | cytolytic granule(GO:0044194) |
| 0.4 | 1.1 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
| 0.4 | 1.5 | GO:0070578 | RISC-loading complex(GO:0070578) |
| 0.4 | 1.5 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.4 | 0.7 | GO:0097444 | spine apparatus(GO:0097444) |
| 0.4 | 2.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
| 0.4 | 0.4 | GO:0031523 | Myb complex(GO:0031523) |
| 0.4 | 2.2 | GO:1990356 | sumoylated E2 ligase complex(GO:1990356) |
| 0.4 | 1.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.4 | 11.8 | GO:0000314 | organellar small ribosomal subunit(GO:0000314) mitochondrial small ribosomal subunit(GO:0005763) |
| 0.4 | 1.4 | GO:0008278 | cohesin complex(GO:0008278) |
| 0.4 | 1.1 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
| 0.4 | 2.8 | GO:0045261 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
| 0.4 | 5.6 | GO:0043196 | varicosity(GO:0043196) |
| 0.3 | 5.5 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
| 0.3 | 2.7 | GO:0046581 | intercellular canaliculus(GO:0046581) |
| 0.3 | 3.1 | GO:0061617 | MICOS complex(GO:0061617) |
| 0.3 | 1.4 | GO:0071942 | XPC complex(GO:0071942) |
| 0.3 | 2.0 | GO:0034448 | EGO complex(GO:0034448) |
| 0.3 | 2.7 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 1.4 | GO:0070436 | Grb2-EGFR complex(GO:0070436) |
| 0.3 | 3.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.3 | 2.6 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.3 | 2.0 | GO:0008540 | proteasome regulatory particle, base subcomplex(GO:0008540) |
| 0.3 | 2.9 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
| 0.3 | 2.6 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.3 | 1.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
| 0.3 | 4.2 | GO:0030057 | desmosome(GO:0030057) |
| 0.3 | 7.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
| 0.3 | 2.5 | GO:0090543 | Flemming body(GO:0090543) |
| 0.3 | 0.9 | GO:0031417 | NatC complex(GO:0031417) |
| 0.3 | 5.3 | GO:0016580 | Sin3 complex(GO:0016580) |
| 0.3 | 1.5 | GO:0045179 | apical cortex(GO:0045179) |
| 0.3 | 1.2 | GO:0097422 | tubular endosome(GO:0097422) |
| 0.3 | 0.9 | GO:0000814 | ESCRT II complex(GO:0000814) |
| 0.3 | 0.3 | GO:0042627 | chylomicron(GO:0042627) |
| 0.3 | 3.9 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
| 0.3 | 0.9 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
| 0.3 | 1.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
| 0.3 | 1.5 | GO:0005861 | troponin complex(GO:0005861) |
| 0.3 | 3.5 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
| 0.3 | 14.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
| 0.3 | 21.0 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.3 | 5.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) |
| 0.3 | 0.9 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
| 0.3 | 0.9 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
| 0.3 | 1.1 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
| 0.3 | 2.0 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
| 0.3 | 2.0 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
| 0.3 | 1.7 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
| 0.3 | 0.3 | GO:0015935 | small ribosomal subunit(GO:0015935) |
| 0.3 | 0.3 | GO:0000811 | GINS complex(GO:0000811) DNA replication preinitiation complex(GO:0031261) |
| 0.3 | 2.8 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
| 0.3 | 3.8 | GO:0072546 | ER membrane protein complex(GO:0072546) |
| 0.3 | 0.8 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
| 0.3 | 1.1 | GO:0032021 | NELF complex(GO:0032021) |
| 0.3 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 1.6 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
| 0.3 | 2.9 | GO:0005915 | zonula adherens(GO:0005915) |
| 0.3 | 0.5 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
| 0.3 | 0.5 | GO:0097135 | cyclin E2-CDK2 complex(GO:0097135) |
| 0.3 | 8.1 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.3 | 2.1 | GO:0060091 | kinocilium(GO:0060091) |
| 0.3 | 0.3 | GO:0097233 | alveolar lamellar body(GO:0097208) lamellar body membrane(GO:0097232) alveolar lamellar body membrane(GO:0097233) |
| 0.3 | 1.0 | GO:0035189 | Rb-E2F complex(GO:0035189) |
| 0.3 | 1.8 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
| 0.3 | 14.2 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
| 0.3 | 3.3 | GO:0046930 | pore complex(GO:0046930) |
| 0.3 | 1.0 | GO:0031095 | platelet dense tubular network membrane(GO:0031095) |
| 0.3 | 0.8 | GO:0000939 | condensed chromosome inner kinetochore(GO:0000939) |
| 0.2 | 1.7 | GO:0070938 | contractile ring(GO:0070938) |
| 0.2 | 0.2 | GO:0031021 | interphase microtubule organizing center(GO:0031021) |
| 0.2 | 0.7 | GO:0032280 | symmetric synapse(GO:0032280) |
| 0.2 | 3.2 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.2 | 4.5 | GO:0032433 | filopodium tip(GO:0032433) |
| 0.2 | 0.5 | GO:0044391 | ribosomal subunit(GO:0044391) |
| 0.2 | 0.7 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
| 0.2 | 1.2 | GO:1903440 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
| 0.2 | 1.6 | GO:0005883 | neurofilament(GO:0005883) |
| 0.2 | 0.7 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
| 0.2 | 0.5 | GO:0031672 | A band(GO:0031672) |
| 0.2 | 3.9 | GO:0031083 | BLOC-1 complex(GO:0031083) |
| 0.2 | 1.4 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 0.2 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
| 0.2 | 0.7 | GO:0005965 | protein farnesyltransferase complex(GO:0005965) |
| 0.2 | 3.9 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.2 | 1.1 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
| 0.2 | 1.9 | GO:0089701 | U2AF(GO:0089701) |
| 0.2 | 3.4 | GO:0005753 | mitochondrial proton-transporting ATP synthase complex(GO:0005753) |
| 0.2 | 0.2 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
| 0.2 | 3.2 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
| 0.2 | 0.6 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
| 0.2 | 1.0 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
| 0.2 | 1.9 | GO:0000796 | condensin complex(GO:0000796) |
| 0.2 | 12.0 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.2 | 1.6 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
| 0.2 | 2.9 | GO:0031011 | Ino80 complex(GO:0031011) |
| 0.2 | 1.0 | GO:0097443 | sorting endosome(GO:0097443) |
| 0.2 | 0.6 | GO:0035061 | interchromatin granule(GO:0035061) |
| 0.2 | 1.6 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.2 | 1.0 | GO:1990357 | terminal web(GO:1990357) |
| 0.2 | 3.9 | GO:0002080 | acrosomal membrane(GO:0002080) |
| 0.2 | 2.9 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
| 0.2 | 2.1 | GO:0005677 | chromatin silencing complex(GO:0005677) |
| 0.2 | 4.0 | GO:0045120 | pronucleus(GO:0045120) |
| 0.2 | 2.1 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
| 0.2 | 5.7 | GO:0000788 | nuclear nucleosome(GO:0000788) |
| 0.2 | 3.2 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.2 | 1.5 | GO:0019867 | outer membrane(GO:0019867) |
| 0.2 | 0.7 | GO:0008623 | CHRAC(GO:0008623) |
| 0.2 | 3.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
| 0.2 | 1.3 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
| 0.2 | 0.4 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
| 0.2 | 1.2 | GO:0098837 | postsynaptic recycling endosome(GO:0098837) |
| 0.2 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
| 0.2 | 2.5 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
| 0.2 | 0.5 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
| 0.2 | 1.2 | GO:0005827 | polar microtubule(GO:0005827) |
| 0.2 | 0.9 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 2.2 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.2 | 1.7 | GO:0032426 | stereocilium tip(GO:0032426) |
| 0.2 | 0.5 | GO:0044291 | cell-cell contact zone(GO:0044291) |
| 0.2 | 0.3 | GO:0044292 | dendrite terminus(GO:0044292) |
| 0.2 | 0.7 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.2 | 3.0 | GO:0071564 | npBAF complex(GO:0071564) |
| 0.2 | 2.0 | GO:0045095 | keratin filament(GO:0045095) |
| 0.2 | 0.7 | GO:0030314 | junctional membrane complex(GO:0030314) |
| 0.2 | 2.6 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.2 | 0.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.2 | 0.6 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 1.3 | GO:0044322 | endoplasmic reticulum quality control compartment(GO:0044322) |
| 0.2 | 2.2 | GO:0005922 | connexon complex(GO:0005922) |
| 0.2 | 0.6 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
| 0.2 | 0.6 | GO:0090537 | CERF complex(GO:0090537) |
| 0.2 | 0.9 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
| 0.1 | 0.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
| 0.1 | 6.7 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.1 | 1.3 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.1 | 7.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
| 0.1 | 0.4 | GO:0048179 | activin receptor complex(GO:0048179) |
| 0.1 | 0.6 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
| 0.1 | 1.3 | GO:0000815 | ESCRT III complex(GO:0000815) |
| 0.1 | 3.4 | GO:0005782 | peroxisomal matrix(GO:0005782) microbody lumen(GO:0031907) |
| 0.1 | 0.4 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
| 0.1 | 0.6 | GO:0042567 | insulin-like growth factor ternary complex(GO:0042567) |
| 0.1 | 1.0 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
| 0.1 | 0.7 | GO:0097226 | sperm mitochondrial sheath(GO:0097226) |
| 0.1 | 1.1 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
| 0.1 | 1.7 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
| 0.1 | 1.4 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.1 | 3.0 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 4.4 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
| 0.1 | 1.9 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
| 0.1 | 0.5 | GO:0008537 | proteasome activator complex(GO:0008537) |
| 0.1 | 0.8 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
| 0.1 | 1.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.1 | 0.8 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
| 0.1 | 0.5 | GO:0030289 | protein phosphatase 4 complex(GO:0030289) |
| 0.1 | 1.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
| 0.1 | 1.2 | GO:0031390 | Ctf18 RFC-like complex(GO:0031390) |
| 0.1 | 1.2 | GO:0034709 | methylosome(GO:0034709) |
| 0.1 | 1.0 | GO:0072687 | meiotic spindle(GO:0072687) |
| 0.1 | 0.6 | GO:0036396 | MIS complex(GO:0036396) mRNA editing complex(GO:0045293) |
| 0.1 | 0.5 | GO:0030891 | VCB complex(GO:0030891) |
| 0.1 | 1.0 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
| 0.1 | 0.4 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 0.1 | 0.8 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
| 0.1 | 1.6 | GO:0030496 | midbody(GO:0030496) |
| 0.1 | 0.5 | GO:0031528 | microvillus membrane(GO:0031528) |
| 0.1 | 0.4 | GO:0044302 | dentate gyrus mossy fiber(GO:0044302) |
| 0.1 | 1.1 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.1 | 0.2 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
| 0.1 | 1.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.1 | 1.4 | GO:0031209 | SCAR complex(GO:0031209) |
| 0.1 | 0.4 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
| 0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
| 0.1 | 1.4 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
| 0.1 | 0.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
| 0.1 | 0.5 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.1 | 0.4 | GO:1990730 | VCP-NSFL1C complex(GO:1990730) |
| 0.1 | 0.1 | GO:0031094 | platelet dense tubular network(GO:0031094) |
| 0.1 | 0.6 | GO:1990037 | Lewy body core(GO:1990037) |
| 0.1 | 0.2 | GO:0070852 | cell body fiber(GO:0070852) |
| 0.1 | 0.3 | GO:0005940 | septin ring(GO:0005940) |
| 0.1 | 0.7 | GO:0032983 | kainate selective glutamate receptor complex(GO:0032983) |
| 0.1 | 0.8 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.6 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
| 0.1 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
| 0.1 | 0.2 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.1 | 0.2 | GO:0097228 | sperm principal piece(GO:0097228) |
| 0.1 | 5.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) intrinsic component of Golgi membrane(GO:0031228) |
| 0.1 | 0.3 | GO:0005655 | nucleolar ribonuclease P complex(GO:0005655) |
| 0.1 | 0.3 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
| 0.1 | 0.7 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
| 0.1 | 0.7 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.1 | 0.4 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.1 | 1.0 | GO:0044754 | secondary lysosome(GO:0005767) autolysosome(GO:0044754) |
| 0.1 | 0.3 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
| 0.1 | 1.7 | GO:0032156 | septin cytoskeleton(GO:0032156) |
| 0.1 | 2.3 | GO:0030285 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
| 0.1 | 0.3 | GO:0031513 | nonmotile primary cilium(GO:0031513) primary cilium(GO:0072372) |
| 0.1 | 0.3 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
| 0.1 | 11.0 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
| 0.1 | 0.2 | GO:0000313 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.1 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
| 0.1 | 0.2 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.1 | 11.0 | GO:0005759 | mitochondrial matrix(GO:0005759) |
| 0.1 | 2.4 | GO:0051233 | spindle midzone(GO:0051233) |
| 0.1 | 0.9 | GO:0031415 | NatA complex(GO:0031415) |
| 0.1 | 30.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.1 | 0.7 | GO:0002177 | manchette(GO:0002177) |
| 0.1 | 0.2 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.1 | 4.1 | GO:0000791 | euchromatin(GO:0000791) |
| 0.1 | 6.0 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 0.7 | GO:0031298 | replication fork protection complex(GO:0031298) |
| 0.1 | 2.9 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 1.1 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
| 0.1 | 0.3 | GO:0043540 | 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase complex(GO:0043540) |
| 0.1 | 0.4 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
| 0.1 | 0.9 | GO:0036452 | ESCRT complex(GO:0036452) |
| 0.1 | 0.2 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
| 0.1 | 1.0 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.1 | 7.4 | GO:0072562 | blood microparticle(GO:0072562) |
| 0.1 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
| 0.1 | 0.8 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 0.5 | GO:0016461 | unconventional myosin complex(GO:0016461) |
| 0.1 | 5.8 | GO:0005581 | collagen trimer(GO:0005581) |
| 0.1 | 1.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
| 0.1 | 0.3 | GO:0034657 | GID complex(GO:0034657) |
| 0.1 | 0.3 | GO:0016514 | SWI/SNF complex(GO:0016514) |
| 0.1 | 0.8 | GO:0061574 | ASAP complex(GO:0061574) |
| 0.1 | 1.5 | GO:0030008 | TRAPP complex(GO:0030008) |
| 0.1 | 1.7 | GO:0032592 | integral component of mitochondrial membrane(GO:0032592) |
| 0.1 | 0.6 | GO:0008305 | integrin complex(GO:0008305) protein complex involved in cell adhesion(GO:0098636) |
| 0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
| 0.1 | 0.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.2 | GO:0097346 | Swr1 complex(GO:0000812) INO80-type complex(GO:0097346) |
| 0.1 | 1.0 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
| 0.1 | 0.7 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.1 | 0.2 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.1 | 0.7 | GO:0030315 | T-tubule(GO:0030315) |
| 0.1 | 0.8 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
| 0.1 | 0.3 | GO:0061702 | inflammasome complex(GO:0061702) |
| 0.1 | 1.1 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 0.2 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
| 0.1 | 0.1 | GO:0070069 | cytochrome complex(GO:0070069) |
| 0.1 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) cytoplasmic side of late endosome membrane(GO:0098560) |
| 0.1 | 0.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
| 0.1 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.4 | GO:0042583 | chromaffin granule(GO:0042583) |
| 0.1 | 0.6 | GO:0031527 | filopodium membrane(GO:0031527) |
| 0.1 | 1.0 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
| 0.1 | 0.3 | GO:0000322 | storage vacuole(GO:0000322) |
| 0.1 | 0.4 | GO:0070847 | core mediator complex(GO:0070847) |
| 0.1 | 0.3 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
| 0.1 | 0.2 | GO:0031510 | SUMO activating enzyme complex(GO:0031510) |
| 0.1 | 6.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.1 | 2.6 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
| 0.1 | 0.9 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
| 0.1 | 0.4 | GO:0005859 | muscle myosin complex(GO:0005859) |
| 0.1 | 0.2 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 0.1 | 1.0 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
| 0.1 | 0.4 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.1 | 0.3 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.1 | 0.9 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.1 | 0.6 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
| 0.1 | 0.9 | GO:0097225 | sperm midpiece(GO:0097225) |
| 0.1 | 2.5 | GO:0005844 | polysome(GO:0005844) |
| 0.1 | 5.6 | GO:0009897 | external side of plasma membrane(GO:0009897) |
| 0.1 | 0.4 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
| 0.1 | 0.4 | GO:0097431 | mitotic spindle pole(GO:0097431) |
| 0.1 | 0.4 | GO:0071565 | nBAF complex(GO:0071565) |
| 0.1 | 0.5 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
| 0.1 | 1.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
| 0.1 | 0.1 | GO:0033180 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) proton-transporting V-type ATPase, V1 domain(GO:0033180) |
| 0.1 | 61.6 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.1 | 0.7 | GO:0030686 | 90S preribosome(GO:0030686) |
| 0.1 | 2.5 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
| 0.1 | 0.2 | GO:0032585 | multivesicular body membrane(GO:0032585) |
| 0.1 | 0.8 | GO:0032039 | integrator complex(GO:0032039) |
| 0.1 | 0.5 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
| 0.1 | 1.4 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
| 0.0 | 0.4 | GO:0032797 | SMN complex(GO:0032797) |
| 0.0 | 0.3 | GO:0005890 | sodium:potassium-exchanging ATPase complex(GO:0005890) |
| 0.0 | 0.6 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
| 0.0 | 1.1 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
| 0.0 | 0.2 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.0 | 0.5 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.0 | 0.0 | GO:0001652 | granular component(GO:0001652) |
| 0.0 | 2.8 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.0 | 0.6 | GO:0005840 | ribosome(GO:0005840) |
| 0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.0 | 0.1 | GO:0005771 | multivesicular body(GO:0005771) |
| 0.0 | 0.4 | GO:0032009 | early phagosome(GO:0032009) |
| 0.0 | 0.6 | GO:0042555 | MCM complex(GO:0042555) |
| 0.0 | 2.8 | GO:0000792 | heterochromatin(GO:0000792) |
| 0.0 | 0.3 | GO:0000938 | GARP complex(GO:0000938) |
| 0.0 | 0.4 | GO:0031931 | TORC1 complex(GO:0031931) |
| 0.0 | 0.3 | GO:0097440 | apical dendrite(GO:0097440) |
| 0.0 | 0.1 | GO:0097255 | R2TP complex(GO:0097255) |
| 0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
| 0.0 | 0.2 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.0 | 0.4 | GO:0042101 | T cell receptor complex(GO:0042101) |
| 0.0 | 0.1 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
| 0.0 | 0.4 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.0 | 0.2 | GO:0097149 | centralspindlin complex(GO:0097149) |
| 0.0 | 1.2 | GO:0035869 | ciliary transition zone(GO:0035869) |
| 0.0 | 1.4 | GO:0005811 | lipid particle(GO:0005811) |
| 0.0 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
| 0.0 | 0.5 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
| 0.0 | 0.2 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
| 0.0 | 59.4 | GO:0070062 | extracellular exosome(GO:0070062) |
| 0.0 | 0.1 | GO:0018444 | translation release factor complex(GO:0018444) |
| 0.0 | 0.4 | GO:0031902 | late endosome membrane(GO:0031902) |
| 0.0 | 0.1 | GO:0016234 | inclusion body(GO:0016234) |
| 0.0 | 0.5 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
| 0.0 | 0.2 | GO:0005921 | gap junction(GO:0005921) |
| 0.0 | 0.8 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.0 | 0.1 | GO:0060187 | cell pole(GO:0060187) |
| 0.0 | 0.1 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
| 0.0 | 0.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
| 0.0 | 0.1 | GO:0034464 | BBSome(GO:0034464) |
| 0.0 | 0.3 | GO:0009925 | basal plasma membrane(GO:0009925) |
| 0.0 | 0.0 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
| 0.0 | 0.0 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.0 | 0.2 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.0 | 0.9 | GO:0005795 | Golgi stack(GO:0005795) |
| 0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
| 0.0 | 0.1 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.0 | 0.4 | GO:0015030 | Cajal body(GO:0015030) |
| 0.0 | 0.2 | GO:0000783 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
| 0.0 | 12.1 | GO:0005576 | extracellular region(GO:0005576) |
| 0.0 | 0.0 | GO:0097413 | Lewy body(GO:0097413) |
| 0.0 | 0.3 | GO:0019866 | organelle inner membrane(GO:0019866) |
| 0.0 | 0.0 | GO:0097361 | CIA complex(GO:0097361) |
| 0.0 | 0.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
| 0.0 | 0.1 | GO:0032300 | mismatch repair complex(GO:0032300) |
| 0.0 | 0.2 | GO:0001741 | XY body(GO:0001741) |
| 0.0 | 0.3 | GO:0044295 | axonal growth cone(GO:0044295) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.3 | 6.9 | GO:0035939 | microsatellite binding(GO:0035939) |
| 1.9 | 9.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
| 1.6 | 4.9 | GO:0009881 | photoreceptor activity(GO:0009881) |
| 1.5 | 6.0 | GO:0017077 | oxidative phosphorylation uncoupler activity(GO:0017077) |
| 1.5 | 4.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
| 1.4 | 7.0 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
| 1.1 | 6.8 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.1 | 5.6 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
| 1.0 | 3.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
| 1.0 | 1.0 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
| 1.0 | 6.0 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
| 1.0 | 4.0 | GO:0004066 | asparagine synthase (glutamine-hydrolyzing) activity(GO:0004066) |
| 1.0 | 4.0 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
| 1.0 | 2.0 | GO:0004921 | interleukin-11 receptor activity(GO:0004921) interleukin-11 binding(GO:0019970) |
| 1.0 | 1.0 | GO:0035198 | miRNA binding(GO:0035198) |
| 0.9 | 2.8 | GO:0005436 | sodium:phosphate symporter activity(GO:0005436) sodium:inorganic phosphate symporter activity(GO:0015319) |
| 0.9 | 4.7 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
| 0.9 | 3.7 | GO:0008073 | ornithine decarboxylase inhibitor activity(GO:0008073) |
| 0.9 | 2.7 | GO:0070052 | collagen V binding(GO:0070052) |
| 0.9 | 0.9 | GO:0071936 | coreceptor activity involved in Wnt signaling pathway(GO:0071936) |
| 0.9 | 2.7 | GO:0004774 | succinate-CoA ligase activity(GO:0004774) |
| 0.9 | 3.5 | GO:0001537 | N-acetylgalactosamine 4-O-sulfotransferase activity(GO:0001537) |
| 0.9 | 2.6 | GO:0005110 | frizzled-2 binding(GO:0005110) |
| 0.8 | 0.8 | GO:0042562 | hormone binding(GO:0042562) |
| 0.8 | 0.8 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
| 0.8 | 2.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
| 0.8 | 10.5 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.7 | 2.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.7 | 2.2 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
| 0.7 | 2.2 | GO:0004127 | cytidylate kinase activity(GO:0004127) |
| 0.7 | 4.4 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
| 0.7 | 2.9 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.7 | 2.2 | GO:0030629 | U6 snRNA 3'-end binding(GO:0030629) |
| 0.7 | 2.0 | GO:0018738 | S-formylglutathione hydrolase activity(GO:0018738) |
| 0.7 | 4.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
| 0.7 | 2.0 | GO:0097677 | STAT family protein binding(GO:0097677) |
| 0.7 | 2.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
| 0.7 | 3.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
| 0.7 | 2.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
| 0.6 | 1.9 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
| 0.6 | 2.5 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.6 | 2.5 | GO:0003844 | 1,4-alpha-glucan branching enzyme activity(GO:0003844) |
| 0.6 | 1.9 | GO:0098973 | structural constituent of synapse(GO:0098918) structural constituent of postsynaptic actin cytoskeleton(GO:0098973) |
| 0.6 | 1.8 | GO:0019912 | cyclin-dependent protein kinase activating kinase activity(GO:0019912) |
| 0.6 | 5.5 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
| 0.6 | 4.9 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
| 0.6 | 3.0 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.6 | 1.8 | GO:0015403 | thiamine uptake transmembrane transporter activity(GO:0015403) |
| 0.6 | 2.3 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
| 0.6 | 4.6 | GO:0008121 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.6 | 6.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
| 0.6 | 4.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
| 0.6 | 5.6 | GO:0008301 | DNA binding, bending(GO:0008301) |
| 0.6 | 3.3 | GO:1990715 | mRNA CDS binding(GO:1990715) |
| 0.5 | 2.2 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
| 0.5 | 2.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
| 0.5 | 1.1 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
| 0.5 | 1.6 | GO:0046592 | polyamine oxidase activity(GO:0046592) spermine:oxygen oxidoreductase (spermidine-forming) activity(GO:0052901) |
| 0.5 | 8.0 | GO:0019215 | intermediate filament binding(GO:0019215) |
| 0.5 | 1.6 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
| 0.5 | 0.5 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
| 0.5 | 2.1 | GO:0097100 | supercoiled DNA binding(GO:0097100) |
| 0.5 | 1.6 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
| 0.5 | 1.6 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
| 0.5 | 1.6 | GO:0051870 | methotrexate binding(GO:0051870) |
| 0.5 | 1.6 | GO:0004450 | isocitrate dehydrogenase (NADP+) activity(GO:0004450) |
| 0.5 | 2.1 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
| 0.5 | 2.1 | GO:0008142 | oxysterol binding(GO:0008142) |
| 0.5 | 3.1 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
| 0.5 | 3.0 | GO:0019841 | retinol binding(GO:0019841) |
| 0.5 | 2.0 | GO:0019213 | deacetylase activity(GO:0019213) |
| 0.5 | 6.5 | GO:0017070 | U6 snRNA binding(GO:0017070) |
| 0.5 | 1.5 | GO:0003977 | UDP-N-acetylglucosamine diphosphorylase activity(GO:0003977) |
| 0.5 | 4.5 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
| 0.5 | 5.9 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.5 | 1.5 | GO:0008177 | succinate dehydrogenase (ubiquinone) activity(GO:0008177) |
| 0.5 | 2.9 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
| 0.5 | 2.9 | GO:0001179 | RNA polymerase I transcription factor binding(GO:0001179) |
| 0.5 | 1.4 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
| 0.5 | 1.4 | GO:0003979 | UDP-glucose 6-dehydrogenase activity(GO:0003979) |
| 0.5 | 6.4 | GO:0030547 | receptor inhibitor activity(GO:0030547) |
| 0.5 | 7.7 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
| 0.5 | 1.8 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
| 0.5 | 3.2 | GO:0019211 | phosphatase activator activity(GO:0019211) |
| 0.5 | 0.5 | GO:0016501 | prostacyclin receptor activity(GO:0016501) |
| 0.5 | 4.5 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
| 0.4 | 0.4 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) phospholipase A2 inhibitor activity(GO:0019834) |
| 0.4 | 0.4 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
| 0.4 | 1.3 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
| 0.4 | 4.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.4 | 2.2 | GO:0034604 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase [NAD(P)+] activity(GO:0034603) pyruvate dehydrogenase (NAD+) activity(GO:0034604) |
| 0.4 | 1.7 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
| 0.4 | 1.3 | GO:0005128 | erythropoietin receptor binding(GO:0005128) |
| 0.4 | 7.3 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
| 0.4 | 2.6 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.4 | 2.1 | GO:0046974 | histone methyltransferase activity (H3-K9 specific)(GO:0046974) |
| 0.4 | 19.8 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
| 0.4 | 2.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
| 0.4 | 2.1 | GO:0052833 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
| 0.4 | 3.3 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
| 0.4 | 1.7 | GO:0004515 | nicotinamide-nucleotide adenylyltransferase activity(GO:0000309) nicotinate-nucleotide adenylyltransferase activity(GO:0004515) |
| 0.4 | 1.2 | GO:0036132 | 13-prostaglandin reductase activity(GO:0036132) 15-oxoprostaglandin 13-oxidase activity(GO:0047522) |
| 0.4 | 1.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
| 0.4 | 3.3 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.4 | 2.5 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.4 | 2.1 | GO:0005534 | galactose binding(GO:0005534) |
| 0.4 | 4.9 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.4 | 1.6 | GO:0046923 | ER retention sequence binding(GO:0046923) |
| 0.4 | 1.2 | GO:0009918 | sterol delta7 reductase activity(GO:0009918) 7-dehydrocholesterol reductase activity(GO:0047598) |
| 0.4 | 0.4 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
| 0.4 | 8.1 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
| 0.4 | 2.0 | GO:0086056 | voltage-gated calcium channel activity involved in AV node cell action potential(GO:0086056) |
| 0.4 | 2.8 | GO:0008430 | selenium binding(GO:0008430) |
| 0.4 | 1.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.4 | 0.4 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
| 0.4 | 1.6 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
| 0.4 | 1.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
| 0.4 | 2.4 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.4 | 2.0 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
| 0.4 | 3.9 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.4 | 1.2 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
| 0.4 | 2.3 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
| 0.4 | 1.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
| 0.4 | 1.5 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.4 | 5.7 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.4 | 15.2 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
| 0.4 | 2.3 | GO:0016863 | intramolecular oxidoreductase activity, transposing C=C bonds(GO:0016863) |
| 0.4 | 3.4 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.4 | 3.7 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
| 0.4 | 1.1 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
| 0.4 | 5.5 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
| 0.4 | 1.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.4 | 2.6 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
| 0.4 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) |
| 0.4 | 1.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.4 | 2.6 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
| 0.4 | 3.6 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
| 0.4 | 1.5 | GO:0008853 | exodeoxyribonuclease III activity(GO:0008853) |
| 0.4 | 1.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.4 | 2.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.4 | 5.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
| 0.4 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.4 | 2.2 | GO:0061656 | SUMO conjugating enzyme activity(GO:0061656) |
| 0.4 | 1.1 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
| 0.4 | 1.1 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.4 | 3.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.4 | 1.4 | GO:0031687 | A2A adenosine receptor binding(GO:0031687) |
| 0.3 | 1.4 | GO:0035851 | Krueppel-associated box domain binding(GO:0035851) |
| 0.3 | 4.9 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
| 0.3 | 1.0 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.3 | 2.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
| 0.3 | 0.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
| 0.3 | 2.4 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
| 0.3 | 1.7 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.3 | 0.7 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.3 | 1.0 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
| 0.3 | 0.7 | GO:0061649 | ubiquitinated histone binding(GO:0061649) |
| 0.3 | 7.0 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.3 | 0.7 | GO:0004174 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
| 0.3 | 3.0 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.3 | 3.9 | GO:0031386 | protein tag(GO:0031386) |
| 0.3 | 1.0 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
| 0.3 | 1.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
| 0.3 | 1.6 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
| 0.3 | 1.0 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
| 0.3 | 1.6 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.3 | 1.0 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
| 0.3 | 1.0 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.3 | 1.0 | GO:0070140 | isopeptidase activity(GO:0070122) ubiquitin-like protein-specific isopeptidase activity(GO:0070138) SUMO-specific isopeptidase activity(GO:0070140) |
| 0.3 | 1.6 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.3 | 2.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.3 | 1.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
| 0.3 | 0.9 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
| 0.3 | 2.2 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
| 0.3 | 0.6 | GO:0034618 | arginine binding(GO:0034618) |
| 0.3 | 7.1 | GO:0003785 | actin monomer binding(GO:0003785) |
| 0.3 | 10.8 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.3 | 2.5 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
| 0.3 | 6.8 | GO:0070410 | co-SMAD binding(GO:0070410) |
| 0.3 | 0.3 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
| 0.3 | 51.4 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.3 | 5.6 | GO:0003746 | translation elongation factor activity(GO:0003746) |
| 0.3 | 2.1 | GO:0036402 | proteasome-activating ATPase activity(GO:0036402) |
| 0.3 | 2.9 | GO:0048406 | nerve growth factor binding(GO:0048406) |
| 0.3 | 1.5 | GO:0031014 | troponin T binding(GO:0031014) |
| 0.3 | 1.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
| 0.3 | 12.2 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.3 | 0.9 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
| 0.3 | 4.6 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
| 0.3 | 3.8 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
| 0.3 | 8.8 | GO:0017147 | Wnt-protein binding(GO:0017147) |
| 0.3 | 0.8 | GO:0004155 | 6,7-dihydropteridine reductase activity(GO:0004155) |
| 0.3 | 0.6 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
| 0.3 | 1.7 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 2.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.3 | 2.5 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
| 0.3 | 0.5 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.3 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.3 | 1.6 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
| 0.3 | 1.4 | GO:0008494 | translation activator activity(GO:0008494) |
| 0.3 | 1.9 | GO:0031748 | D1 dopamine receptor binding(GO:0031748) |
| 0.3 | 1.1 | GO:1990460 | leptin receptor binding(GO:1990460) |
| 0.3 | 0.5 | GO:0004017 | adenylate kinase activity(GO:0004017) |
| 0.3 | 5.0 | GO:0017049 | GTP-Rho binding(GO:0017049) |
| 0.3 | 1.8 | GO:0001222 | transcription corepressor binding(GO:0001222) |
| 0.3 | 2.1 | GO:0001094 | TFIID-class transcription factor binding(GO:0001094) |
| 0.3 | 1.3 | GO:0019770 | IgG receptor activity(GO:0019770) |
| 0.3 | 1.0 | GO:1904288 | BAT3 complex binding(GO:1904288) |
| 0.3 | 1.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.3 | 0.8 | GO:0003963 | RNA-3'-phosphate cyclase activity(GO:0003963) |
| 0.3 | 0.8 | GO:0071207 | histone pre-mRNA stem-loop binding(GO:0071207) |
| 0.3 | 3.8 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
| 0.3 | 0.8 | GO:0031208 | POZ domain binding(GO:0031208) |
| 0.3 | 14.3 | GO:0019003 | GDP binding(GO:0019003) |
| 0.2 | 1.5 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
| 0.2 | 1.0 | GO:0097003 | adiponectin binding(GO:0055100) adipokinetic hormone receptor activity(GO:0097003) |
| 0.2 | 1.5 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
| 0.2 | 0.7 | GO:0046538 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
| 0.2 | 1.2 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.2 | 2.2 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.2 | 0.7 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
| 0.2 | 13.8 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
| 0.2 | 0.7 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.2 | 0.7 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
| 0.2 | 1.2 | GO:0070330 | aromatase activity(GO:0070330) |
| 0.2 | 1.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.2 | 0.7 | GO:0002060 | purine nucleobase binding(GO:0002060) |
| 0.2 | 0.7 | GO:0003858 | 3-hydroxybutyrate dehydrogenase activity(GO:0003858) |
| 0.2 | 1.2 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.2 | 0.7 | GO:0017150 | tRNA dihydrouridine synthase activity(GO:0017150) |
| 0.2 | 0.7 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
| 0.2 | 1.4 | GO:0016453 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
| 0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
| 0.2 | 1.2 | GO:0097643 | amylin receptor activity(GO:0097643) |
| 0.2 | 0.5 | GO:0043559 | insulin binding(GO:0043559) |
| 0.2 | 0.9 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
| 0.2 | 1.6 | GO:0015288 | porin activity(GO:0015288) |
| 0.2 | 0.7 | GO:0047751 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) enone reductase activity(GO:0035671) cholestenone 5-alpha-reductase activity(GO:0047751) |
| 0.2 | 1.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
| 0.2 | 1.1 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
| 0.2 | 0.9 | GO:0042806 | fucose binding(GO:0042806) |
| 0.2 | 1.1 | GO:0003839 | gamma-glutamylcyclotransferase activity(GO:0003839) |
| 0.2 | 1.4 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.2 | 1.1 | GO:0070883 | pre-miRNA binding(GO:0070883) |
| 0.2 | 0.9 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
| 0.2 | 0.9 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
| 0.2 | 4.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.2 | 1.8 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
| 0.2 | 0.7 | GO:0004660 | protein farnesyltransferase activity(GO:0004660) |
| 0.2 | 2.0 | GO:0048185 | activin binding(GO:0048185) |
| 0.2 | 4.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
| 0.2 | 1.3 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
| 0.2 | 2.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 1.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.2 | 0.9 | GO:0001851 | complement component C3b binding(GO:0001851) |
| 0.2 | 0.4 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
| 0.2 | 0.4 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
| 0.2 | 0.4 | GO:0001227 | transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001227) |
| 0.2 | 1.3 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.2 | 12.1 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 1.9 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
| 0.2 | 1.5 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
| 0.2 | 4.6 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
| 0.2 | 2.7 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
| 0.2 | 2.5 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
| 0.2 | 2.9 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
| 0.2 | 3.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
| 0.2 | 0.6 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
| 0.2 | 1.2 | GO:0001515 | opioid peptide activity(GO:0001515) |
| 0.2 | 0.8 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
| 0.2 | 1.0 | GO:0015142 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
| 0.2 | 0.8 | GO:0003998 | acylphosphatase activity(GO:0003998) |
| 0.2 | 0.2 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
| 0.2 | 6.2 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
| 0.2 | 2.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
| 0.2 | 0.6 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.2 | 1.4 | GO:0061665 | SUMO ligase activity(GO:0061665) |
| 0.2 | 0.6 | GO:0008515 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
| 0.2 | 4.2 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.2 | 1.4 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
| 0.2 | 0.4 | GO:0001042 | RNA polymerase I core binding(GO:0001042) |
| 0.2 | 0.6 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
| 0.2 | 0.6 | GO:0034597 | phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) |
| 0.2 | 0.8 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.2 | 4.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.2 | 1.0 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 0.2 | 2.7 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.2 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
| 0.2 | 0.8 | GO:0003883 | CTP synthase activity(GO:0003883) |
| 0.2 | 2.1 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.2 | 2.3 | GO:0050692 | DBD domain binding(GO:0050692) |
| 0.2 | 1.1 | GO:0017040 | ceramidase activity(GO:0017040) |
| 0.2 | 0.6 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.2 | 0.9 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
| 0.2 | 1.1 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
| 0.2 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
| 0.2 | 0.4 | GO:0008534 | oxidized purine nucleobase lesion DNA N-glycosylase activity(GO:0008534) |
| 0.2 | 0.6 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
| 0.2 | 3.9 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.2 | 6.6 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
| 0.2 | 0.6 | GO:0004140 | dephospho-CoA kinase activity(GO:0004140) |
| 0.2 | 0.7 | GO:0003941 | L-serine ammonia-lyase activity(GO:0003941) |
| 0.2 | 0.7 | GO:2001069 | glycogen binding(GO:2001069) |
| 0.2 | 5.2 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) |
| 0.2 | 1.2 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.2 | 0.7 | GO:0070991 | medium-chain-acyl-CoA dehydrogenase activity(GO:0070991) |
| 0.2 | 2.7 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 2.0 | GO:0016805 | dipeptidase activity(GO:0016805) |
| 0.2 | 0.4 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
| 0.2 | 3.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.2 | 0.5 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
| 0.2 | 0.5 | GO:0051425 | PTB domain binding(GO:0051425) |
| 0.2 | 0.5 | GO:0004022 | alcohol dehydrogenase (NAD) activity(GO:0004022) |
| 0.2 | 3.8 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 0.8 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
| 0.2 | 1.0 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.2 | 0.5 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
| 0.2 | 0.7 | GO:0001847 | opsonin receptor activity(GO:0001847) |
| 0.2 | 3.9 | GO:0097602 | cullin family protein binding(GO:0097602) |
| 0.2 | 2.2 | GO:0004576 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
| 0.2 | 1.8 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.2 | 1.3 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.2 | 1.5 | GO:0070513 | death domain binding(GO:0070513) |
| 0.2 | 0.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
| 0.2 | 0.5 | GO:0004454 | ketohexokinase activity(GO:0004454) |
| 0.2 | 0.2 | GO:0008948 | oxaloacetate decarboxylase activity(GO:0008948) |
| 0.2 | 8.3 | GO:0002039 | p53 binding(GO:0002039) |
| 0.2 | 1.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
| 0.2 | 2.0 | GO:0070097 | delta-catenin binding(GO:0070097) |
| 0.2 | 0.5 | GO:0004816 | asparagine-tRNA ligase activity(GO:0004816) |
| 0.2 | 0.6 | GO:0070492 | oligosaccharide binding(GO:0070492) |
| 0.2 | 0.3 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
| 0.2 | 0.2 | GO:1903135 | cupric ion binding(GO:1903135) |
| 0.2 | 0.8 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
| 0.2 | 2.8 | GO:0043422 | protein kinase B binding(GO:0043422) |
| 0.2 | 0.9 | GO:0070628 | proteasome binding(GO:0070628) |
| 0.2 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.2 | 1.1 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
| 0.2 | 0.2 | GO:0070404 | NADH binding(GO:0070404) |
| 0.2 | 1.5 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
| 0.2 | 1.7 | GO:0001618 | virus receptor activity(GO:0001618) |
| 0.2 | 1.1 | GO:0030957 | Tat protein binding(GO:0030957) |
| 0.2 | 4.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
| 0.2 | 1.8 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.1 | 1.8 | GO:0005522 | profilin binding(GO:0005522) |
| 0.1 | 0.1 | GO:0008988 | rRNA (adenine-N6-)-methyltransferase activity(GO:0008988) |
| 0.1 | 0.3 | GO:0016417 | S-acyltransferase activity(GO:0016417) |
| 0.1 | 0.7 | GO:0001226 | RNA polymerase II transcription corepressor binding(GO:0001226) |
| 0.1 | 0.3 | GO:0038085 | vascular endothelial growth factor binding(GO:0038085) |
| 0.1 | 1.2 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.1 | 0.1 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.1 | 1.0 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
| 0.1 | 0.9 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
| 0.1 | 0.7 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
| 0.1 | 4.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.1 | 1.0 | GO:0034452 | dynactin binding(GO:0034452) |
| 0.1 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
| 0.1 | 1.9 | GO:0035497 | cAMP response element binding(GO:0035497) |
| 0.1 | 2.1 | GO:0055106 | ubiquitin-protein transferase regulator activity(GO:0055106) |
| 0.1 | 0.6 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
| 0.1 | 1.6 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
| 0.1 | 1.3 | GO:0008199 | ferric iron binding(GO:0008199) |
| 0.1 | 0.6 | GO:0023023 | MHC protein complex binding(GO:0023023) MHC class II protein complex binding(GO:0023026) |
| 0.1 | 0.6 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.1 | 0.3 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
| 0.1 | 2.8 | GO:0004707 | MAP kinase activity(GO:0004707) |
| 0.1 | 0.8 | GO:0022884 | macromolecule transmembrane transporter activity(GO:0022884) |
| 0.1 | 0.4 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
| 0.1 | 1.0 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
| 0.1 | 0.6 | GO:1990459 | transferrin receptor binding(GO:1990459) |
| 0.1 | 0.5 | GO:0016151 | nickel cation binding(GO:0016151) |
| 0.1 | 3.3 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.1 | 1.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
| 0.1 | 1.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
| 0.1 | 0.4 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
| 0.1 | 1.2 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
| 0.1 | 0.4 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
| 0.1 | 1.7 | GO:0001013 | RNA polymerase I regulatory region DNA binding(GO:0001013) |
| 0.1 | 0.4 | GO:0043237 | laminin-1 binding(GO:0043237) |
| 0.1 | 0.5 | GO:0016708 | nitric oxide dioxygenase activity(GO:0008941) oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of two atoms of oxygen into one donor(GO:0016708) iron-cytochrome-c reductase activity(GO:0047726) |
| 0.1 | 0.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
| 0.1 | 0.5 | GO:0003681 | bent DNA binding(GO:0003681) |
| 0.1 | 0.5 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
| 0.1 | 0.8 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
| 0.1 | 0.4 | GO:0004482 | mRNA (guanine-N7-)-methyltransferase activity(GO:0004482) |
| 0.1 | 0.9 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
| 0.1 | 0.5 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
| 0.1 | 0.8 | GO:0003680 | AT DNA binding(GO:0003680) |
| 0.1 | 0.8 | GO:0001047 | core promoter binding(GO:0001047) |
| 0.1 | 1.5 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
| 0.1 | 6.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.1 | 1.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 0.1 | 0.1 | GO:0050816 | phosphothreonine binding(GO:0050816) |
| 0.1 | 2.4 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
| 0.1 | 0.5 | GO:0070051 | fibrinogen binding(GO:0070051) |
| 0.1 | 3.2 | GO:0050136 | NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.1 | 0.6 | GO:0004359 | glutaminase activity(GO:0004359) |
| 0.1 | 12.5 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
| 0.1 | 1.2 | GO:0009055 | electron carrier activity(GO:0009055) |
| 0.1 | 0.7 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
| 0.1 | 1.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
| 0.1 | 1.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.1 | 0.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
| 0.1 | 0.4 | GO:0016979 | lipoate-protein ligase activity(GO:0016979) |
| 0.1 | 0.6 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.1 | 0.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
| 0.1 | 0.9 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
| 0.1 | 1.0 | GO:1990446 | U1 snRNP binding(GO:1990446) |
| 0.1 | 0.7 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
| 0.1 | 1.5 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.1 | 1.7 | GO:0042056 | chemoattractant activity(GO:0042056) |
| 0.1 | 0.3 | GO:0030156 | benzodiazepine receptor binding(GO:0030156) |
| 0.1 | 0.7 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
| 0.1 | 0.5 | GO:0015114 | phosphate ion transmembrane transporter activity(GO:0015114) |
| 0.1 | 1.2 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
| 0.1 | 0.4 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.1 | 0.8 | GO:0017166 | vinculin binding(GO:0017166) |
| 0.1 | 0.3 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
| 0.1 | 0.3 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
| 0.1 | 0.2 | GO:0042813 | Wnt-activated receptor activity(GO:0042813) |
| 0.1 | 0.1 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
| 0.1 | 0.7 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
| 0.1 | 1.8 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.9 | GO:0015087 | cobalt ion transmembrane transporter activity(GO:0015087) |
| 0.1 | 1.1 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
| 0.1 | 1.0 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen(GO:0016702) |
| 0.1 | 0.5 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
| 0.1 | 0.4 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
| 0.1 | 2.5 | GO:0070717 | poly-purine tract binding(GO:0070717) |
| 0.1 | 0.2 | GO:0016840 | carbon-nitrogen lyase activity(GO:0016840) |
| 0.1 | 1.3 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.1 | 1.4 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
| 0.1 | 0.3 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
| 0.1 | 0.2 | GO:0032356 | oxidized DNA binding(GO:0032356) |
| 0.1 | 0.2 | GO:0032407 | MutSalpha complex binding(GO:0032407) |
| 0.1 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.1 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.1 | 0.5 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
| 0.1 | 7.4 | GO:0008083 | growth factor activity(GO:0008083) |
| 0.1 | 1.1 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
| 0.1 | 0.4 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
| 0.1 | 0.1 | GO:0010851 | cyclase regulator activity(GO:0010851) |
| 0.1 | 0.3 | GO:0047256 | beta-galactosyl-N-acetylglucosaminylgalactosylglucosyl-ceramide beta-1,3-acetylglucosaminyltransferase activity(GO:0008457) lactosylceramide 1,3-N-acetyl-beta-D-glucosaminyltransferase activity(GO:0047256) |
| 0.1 | 2.1 | GO:0016289 | CoA hydrolase activity(GO:0016289) |
| 0.1 | 0.5 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
| 0.1 | 0.2 | GO:0051379 | epinephrine binding(GO:0051379) |
| 0.1 | 0.5 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.1 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
| 0.1 | 2.9 | GO:0019707 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
| 0.1 | 0.2 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
| 0.1 | 0.4 | GO:0004392 | heme oxygenase (decyclizing) activity(GO:0004392) |
| 0.1 | 0.2 | GO:0030151 | molybdenum ion binding(GO:0030151) |
| 0.1 | 0.3 | GO:0004980 | melanocortin receptor activity(GO:0004977) melanocyte-stimulating hormone receptor activity(GO:0004980) |
| 0.1 | 0.4 | GO:0031493 | nucleosomal histone binding(GO:0031493) hemi-methylated DNA-binding(GO:0044729) |
| 0.1 | 0.7 | GO:0008428 | ribonuclease inhibitor activity(GO:0008428) |
| 0.1 | 0.4 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) |
| 0.1 | 0.5 | GO:0005052 | peroxisome matrix targeting signal-1 binding(GO:0005052) |
| 0.1 | 0.1 | GO:0032052 | bile acid binding(GO:0032052) |
| 0.1 | 0.7 | GO:0048101 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) calcium- and calmodulin-regulated 3',5'-cyclic-GMP phosphodiesterase activity(GO:0048101) |
| 0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
| 0.1 | 0.4 | GO:0031720 | haptoglobin binding(GO:0031720) |
| 0.1 | 0.3 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
| 0.1 | 0.8 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
| 0.1 | 0.6 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
| 0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
| 0.1 | 0.3 | GO:0005118 | sevenless binding(GO:0005118) |
| 0.1 | 2.2 | GO:0005112 | Notch binding(GO:0005112) |
| 0.1 | 0.2 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
| 0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.1 | 1.0 | GO:0020037 | heme binding(GO:0020037) |
| 0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
| 0.1 | 0.4 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.1 | 0.1 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
| 0.1 | 1.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.1 | 2.8 | GO:0004364 | glutathione transferase activity(GO:0004364) |
| 0.1 | 2.0 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 2.2 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.3 | GO:0001729 | ceramide kinase activity(GO:0001729) |
| 0.1 | 4.8 | GO:0003730 | mRNA 3'-UTR binding(GO:0003730) |
| 0.1 | 0.3 | GO:0048038 | quinone binding(GO:0048038) |
| 0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.1 | 1.7 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
| 0.1 | 0.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
| 0.1 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
| 0.1 | 0.1 | GO:0019864 | immunoglobulin receptor activity(GO:0019763) IgG binding(GO:0019864) |
| 0.1 | 1.0 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
| 0.1 | 0.2 | GO:0043532 | angiostatin binding(GO:0043532) |
| 0.1 | 0.3 | GO:0001032 | RNA polymerase III type 3 promoter DNA binding(GO:0001032) |
| 0.1 | 0.3 | GO:0010181 | FMN binding(GO:0010181) |
| 0.1 | 0.2 | GO:0070061 | fructose binding(GO:0070061) |
| 0.1 | 0.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.1 | 0.2 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 0.1 | 0.2 | GO:0061711 | N(6)-L-threonylcarbamoyladenine synthase(GO:0061711) |
| 0.1 | 1.0 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
| 0.1 | 1.3 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 0.2 | GO:0004466 | long-chain-acyl-CoA dehydrogenase activity(GO:0004466) |
| 0.1 | 0.3 | GO:0038049 | glucocorticoid receptor activity(GO:0004883) transcription factor activity, ligand-activated RNA polymerase II transcription factor binding(GO:0038049) glucocorticoid-activated RNA polymerase II transcription factor binding transcription factor activity(GO:0038051) |
| 0.1 | 0.4 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
| 0.1 | 0.2 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
| 0.1 | 0.3 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
| 0.1 | 0.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
| 0.1 | 0.5 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.1 | 0.3 | GO:0050347 | trans-hexaprenyltranstransferase activity(GO:0000010) trans-octaprenyltranstransferase activity(GO:0050347) |
| 0.1 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
| 0.1 | 0.4 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.1 | 5.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.1 | 0.7 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
| 0.1 | 0.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
| 0.1 | 1.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
| 0.1 | 0.3 | GO:0042731 | PH domain binding(GO:0042731) |
| 0.1 | 1.9 | GO:0016876 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 1.6 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
| 0.1 | 0.5 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.1 | 0.6 | GO:0015250 | water channel activity(GO:0015250) |
| 0.1 | 5.1 | GO:0008201 | heparin binding(GO:0008201) |
| 0.1 | 0.7 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.1 | 0.2 | GO:0008109 | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity(GO:0008109) |
| 0.1 | 0.3 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
| 0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
| 0.1 | 0.3 | GO:0089720 | caspase binding(GO:0089720) |
| 0.1 | 0.2 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
| 0.1 | 0.2 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
| 0.1 | 0.6 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
| 0.1 | 0.3 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
| 0.1 | 0.1 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
| 0.1 | 1.1 | GO:0048029 | monosaccharide binding(GO:0048029) |
| 0.1 | 4.9 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.1 | 0.3 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
| 0.1 | 0.4 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
| 0.1 | 0.3 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
| 0.1 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
| 0.1 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
| 0.1 | 1.6 | GO:0016836 | hydro-lyase activity(GO:0016836) |
| 0.1 | 0.1 | GO:0005290 | L-histidine transmembrane transporter activity(GO:0005290) |
| 0.1 | 0.7 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
| 0.1 | 0.2 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 0.5 | GO:0045182 | translation regulator activity(GO:0045182) |
| 0.1 | 0.1 | GO:0046969 | histone deacetylase activity (H3-K9 specific)(GO:0032129) NAD-dependent histone deacetylase activity (H3-K9 specific)(GO:0046969) |
| 0.1 | 0.3 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
| 0.1 | 1.9 | GO:0030332 | cyclin binding(GO:0030332) |
| 0.1 | 5.4 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
| 0.1 | 0.2 | GO:0016314 | phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity(GO:0016314) |
| 0.1 | 0.7 | GO:0051861 | glycolipid binding(GO:0051861) |
| 0.1 | 0.2 | GO:0005048 | signal sequence binding(GO:0005048) |
| 0.1 | 1.5 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 2.3 | GO:0005179 | hormone activity(GO:0005179) |
| 0.1 | 0.2 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
| 0.1 | 2.5 | GO:0005506 | iron ion binding(GO:0005506) |
| 0.1 | 1.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.1 | 0.2 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
| 0.1 | 0.2 | GO:0035174 | histone serine kinase activity(GO:0035174) |
| 0.1 | 0.2 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
| 0.1 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.1 | 1.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
| 0.0 | 0.5 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
| 0.0 | 0.1 | GO:0050700 | CARD domain binding(GO:0050700) |
| 0.0 | 2.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
| 0.0 | 0.8 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
| 0.0 | 0.2 | GO:0004321 | fatty-acyl-CoA synthase activity(GO:0004321) |
| 0.0 | 0.2 | GO:0016742 | hydroxymethyl-, formyl- and related transferase activity(GO:0016742) |
| 0.0 | 0.2 | GO:0098518 | polynucleotide 3'-phosphatase activity(GO:0046403) polynucleotide phosphatase activity(GO:0098518) |
| 0.0 | 0.4 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
| 0.0 | 0.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.0 | 0.1 | GO:0016300 | tRNA (uracil) methyltransferase activity(GO:0016300) |
| 0.0 | 0.1 | GO:0009019 | tRNA (guanine-N1-)-methyltransferase activity(GO:0009019) |
| 0.0 | 0.1 | GO:0004658 | propionyl-CoA carboxylase activity(GO:0004658) |
| 0.0 | 0.2 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.0 | 1.7 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.0 | 0.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
| 0.0 | 0.2 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.0 | 1.6 | GO:0005080 | protein kinase C binding(GO:0005080) |
| 0.0 | 0.1 | GO:0043758 | acetate-CoA ligase (ADP-forming) activity(GO:0043758) |
| 0.0 | 0.1 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.2 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
| 0.0 | 1.1 | GO:0001671 | ATPase activator activity(GO:0001671) |
| 0.0 | 0.3 | GO:0003993 | acid phosphatase activity(GO:0003993) |
| 0.0 | 0.2 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
| 0.0 | 0.1 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
| 0.0 | 0.2 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
| 0.0 | 0.1 | GO:0015265 | urea channel activity(GO:0015265) |
| 0.0 | 0.1 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) phosphatidylserine 1-acylhydrolase activity(GO:0052739) 1-acyl-2-lysophosphatidylserine acylhydrolase activity(GO:0052740) |
| 0.0 | 0.2 | GO:0015350 | methotrexate transporter activity(GO:0015350) |
| 0.0 | 0.2 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
| 0.0 | 1.7 | GO:0004004 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
| 0.0 | 0.0 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
| 0.0 | 0.4 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.0 | 0.6 | GO:0008483 | transaminase activity(GO:0008483) |
| 0.0 | 0.2 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
| 0.0 | 1.1 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.0 | 0.8 | GO:0005109 | frizzled binding(GO:0005109) |
| 0.0 | 0.2 | GO:0048403 | brain-derived neurotrophic factor binding(GO:0048403) |
| 0.0 | 0.1 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.0 | 0.2 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
| 0.0 | 0.1 | GO:0004103 | choline kinase activity(GO:0004103) |
| 0.0 | 0.1 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
| 0.0 | 0.1 | GO:0003880 | protein C-terminal carboxyl O-methyltransferase activity(GO:0003880) |
| 0.0 | 1.5 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
| 0.0 | 1.0 | GO:0048487 | beta-tubulin binding(GO:0048487) |
| 0.0 | 0.1 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
| 0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
| 0.0 | 0.1 | GO:0004064 | arylesterase activity(GO:0004064) |
| 0.0 | 0.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
| 0.0 | 0.0 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 0.0 | 0.8 | GO:0004177 | aminopeptidase activity(GO:0004177) |
| 0.0 | 0.1 | GO:0009383 | rRNA (cytosine-C5-)-methyltransferase activity(GO:0009383) |
| 0.0 | 0.6 | GO:0000175 | 3'-5'-exoribonuclease activity(GO:0000175) |
| 0.0 | 0.2 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
| 0.0 | 0.4 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
| 0.0 | 2.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
| 0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
| 0.0 | 0.4 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.0 | 0.0 | GO:0042328 | heparan sulfate N-acetylglucosaminyltransferase activity(GO:0042328) |
| 0.0 | 0.1 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
| 0.0 | 0.6 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.0 | 0.8 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.4 | GO:0016209 | antioxidant activity(GO:0016209) |
| 0.0 | 1.1 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
| 0.0 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.0 | 0.2 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
| 0.0 | 0.3 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.0 | 0.2 | GO:0016208 | AMP binding(GO:0016208) |
| 0.0 | 0.1 | GO:0019534 | toxin transporter activity(GO:0019534) |
| 0.0 | 0.0 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
| 0.0 | 0.0 | GO:0030984 | kininogen binding(GO:0030984) |
| 0.0 | 0.2 | GO:0019531 | secondary active sulfate transmembrane transporter activity(GO:0008271) oxalate transmembrane transporter activity(GO:0019531) |
| 0.0 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.0 | 0.0 | GO:0052743 | inositol tetrakisphosphate phosphatase activity(GO:0052743) |
| 0.0 | 0.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
| 0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.0 | 0.0 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.0 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) |
| 0.0 | 0.0 | GO:0008097 | 5S rRNA binding(GO:0008097) |
| 0.0 | 0.1 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
| 0.0 | 0.1 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.0 | 0.0 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor(GO:0016653) |
| 0.0 | 0.1 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
| 0.0 | 0.1 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
| 0.0 | 0.1 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
| 0.0 | 0.0 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
| 0.0 | 0.1 | GO:0046977 | TAP binding(GO:0046977) |
| 0.0 | 0.0 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.0 | 0.1 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.9 | 12.0 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.7 | 2.0 | PID_EPHA2_FWD_PATHWAY | EPHA2 forward signaling |
| 0.5 | 15.1 | PID_WNT_SIGNALING_PATHWAY | Wnt signaling network |
| 0.5 | 0.5 | PID_TXA2PATHWAY | Thromboxane A2 receptor signaling |
| 0.4 | 9.3 | PID_HIF1A_PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
| 0.4 | 1.2 | PID_SYNDECAN_1_PATHWAY | Syndecan-1-mediated signaling events |
| 0.3 | 9.6 | PID_PRL_SIGNALING_EVENTS_PATHWAY | Signaling events mediated by PRL |
| 0.3 | 8.4 | SA_TRKA_RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
| 0.3 | 1.4 | PID_LYMPH_ANGIOGENESIS_PATHWAY | VEGFR3 signaling in lymphatic endothelium |
| 0.3 | 1.0 | PID_PDGFRA_PATHWAY | PDGFR-alpha signaling pathway |
| 0.3 | 9.5 | PID_HES_HEY_PATHWAY | Notch-mediated HES/HEY network |
| 0.2 | 8.6 | PID_ALK1_PATHWAY | ALK1 signaling events |
| 0.2 | 7.1 | PID_SYNDECAN_4_PATHWAY | Syndecan-4-mediated signaling events |
| 0.2 | 9.1 | PID_P38_MK2_PATHWAY | p38 signaling mediated by MAPKAP kinases |
| 0.2 | 2.8 | PID_VEGF_VEGFR_PATHWAY | VEGF and VEGFR signaling network |
| 0.2 | 3.3 | PID_INTEGRIN5_PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
| 0.2 | 22.3 | PID_HDAC_CLASSI_PATHWAY | Signaling events mediated by HDAC Class I |
| 0.2 | 25.8 | PID_MYC_ACTIV_PATHWAY | Validated targets of C-MYC transcriptional activation |
| 0.2 | 1.4 | PID_SMAD2_3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
| 0.2 | 8.4 | PID_ILK_PATHWAY | Integrin-linked kinase signaling |
| 0.2 | 8.5 | PID_HNF3B_PATHWAY | FOXA2 and FOXA3 transcription factor networks |
| 0.2 | 18.6 | PID_AR_PATHWAY | Coregulation of Androgen receptor activity |
| 0.2 | 3.8 | PID_AURORA_A_PATHWAY | Aurora A signaling |
| 0.2 | 0.6 | PID_RANBP2_PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
| 0.2 | 9.4 | NABA_COLLAGENS | Genes encoding collagen proteins |
| 0.2 | 1.4 | PID_NFAT_3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
| 0.2 | 7.1 | PID_BMP_PATHWAY | BMP receptor signaling |
| 0.2 | 4.2 | PID_BARD1_PATHWAY | BARD1 signaling events |
| 0.2 | 1.9 | PID_IFNG_PATHWAY | IFN-gamma pathway |
| 0.2 | 9.2 | PID_AP1_PATHWAY | AP-1 transcription factor network |
| 0.2 | 1.1 | PID_PTP1B_PATHWAY | Signaling events mediated by PTP1B |
| 0.2 | 7.6 | PID_AURORA_B_PATHWAY | Aurora B signaling |
| 0.2 | 0.4 | PID_ALK2_PATHWAY | ALK2 signaling events |
| 0.2 | 14.3 | WNT_SIGNALING | Genes related to Wnt-mediated signal transduction |
| 0.2 | 0.2 | PID_NFKAPPAB_ATYPICAL_PATHWAY | Atypical NF-kappaB pathway |
| 0.2 | 1.8 | PID_INTEGRIN2_PATHWAY | Beta2 integrin cell surface interactions |
| 0.2 | 3.3 | PID_HIF2PATHWAY | HIF-2-alpha transcription factor network |
| 0.2 | 5.7 | PID_RAS_PATHWAY | Regulation of Ras family activation |
| 0.2 | 1.7 | PID_ERB_GENOMIC_PATHWAY | Validated nuclear estrogen receptor beta network |
| 0.2 | 3.0 | PID_TCR_CALCIUM_PATHWAY | Calcium signaling in the CD4+ TCR pathway |
| 0.2 | 2.0 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.2 | 0.3 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.2 | 6.8 | PID_ERA_GENOMIC_PATHWAY | Validated nuclear estrogen receptor alpha network |
| 0.1 | 0.3 | PID_SYNDECAN_3_PATHWAY | Syndecan-3-mediated signaling events |
| 0.1 | 2.9 | PID_EPHRINB_REV_PATHWAY | Ephrin B reverse signaling |
| 0.1 | 3.3 | PID_RET_PATHWAY | Signaling events regulated by Ret tyrosine kinase |
| 0.1 | 1.0 | PID_SYNDECAN_2_PATHWAY | Syndecan-2-mediated signaling events |
| 0.1 | 7.3 | PID_RAC1_PATHWAY | RAC1 signaling pathway |
| 0.1 | 0.7 | SA_B_CELL_RECEPTOR_COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
| 0.1 | 3.5 | PID_FOXO_PATHWAY | FoxO family signaling |
| 0.1 | 2.3 | PID_GLYPICAN_1PATHWAY | Glypican 1 network |
| 0.1 | 0.3 | ST_IL_13_PATHWAY | Interleukin 13 (IL-13) Pathway |
| 0.1 | 0.5 | PID_ANTHRAX_PATHWAY | Cellular roles of Anthrax toxin |
| 0.1 | 8.0 | PID_P73PATHWAY | p73 transcription factor network |
| 0.1 | 2.3 | PID_NFAT_TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
| 0.1 | 1.2 | PID_FRA_PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
| 0.1 | 0.1 | PID_IL2_STAT5_PATHWAY | IL2 signaling events mediated by STAT5 |
| 0.1 | 2.3 | PID_NECTIN_PATHWAY | Nectin adhesion pathway |
| 0.1 | 0.6 | PID_INTEGRIN1_PATHWAY | Beta1 integrin cell surface interactions |
| 0.1 | 0.1 | PID_IGF1_PATHWAY | IGF1 pathway |
| 0.1 | 3.3 | PID_TGFBR_PATHWAY | TGF-beta receptor signaling |
| 0.1 | 13.9 | NABA_SECRETED_FACTORS | Genes encoding secreted soluble factors |
| 0.1 | 3.2 | PID_CMYB_PATHWAY | C-MYB transcription factor network |
| 0.1 | 1.8 | PID_ATF2_PATHWAY | ATF-2 transcription factor network |
| 0.1 | 0.7 | PID_IL4_2PATHWAY | IL4-mediated signaling events |
| 0.1 | 2.2 | PID_FANCONI_PATHWAY | Fanconi anemia pathway |
| 0.1 | 0.8 | PID_FCER1_PATHWAY | Fc-epsilon receptor I signaling in mast cells |
| 0.1 | 0.9 | PID_IL2_1PATHWAY | IL2-mediated signaling events |
| 0.1 | 1.1 | PID_FGF_PATHWAY | FGF signaling pathway |
| 0.1 | 1.8 | PID_RETINOIC_ACID_PATHWAY | Retinoic acid receptors-mediated signaling |
| 0.1 | 3.1 | PID_E2F_PATHWAY | E2F transcription factor network |
| 0.1 | 0.1 | PID_MYC_PATHWAY | C-MYC pathway |
| 0.1 | 3.1 | PID_P75_NTR_PATHWAY | p75(NTR)-mediated signaling |
| 0.1 | 1.1 | PID_SMAD2_3NUCLEAR_PATHWAY | Regulation of nuclear SMAD2/3 signaling |
| 0.1 | 0.7 | PID_IL3_PATHWAY | IL3-mediated signaling events |
| 0.1 | 0.2 | PID_TCR_JNK_PATHWAY | JNK signaling in the CD4+ TCR pathway |
| 0.1 | 1.2 | PID_HIF1_TFPATHWAY | HIF-1-alpha transcription factor network |
| 0.1 | 1.7 | PID_BETA_CATENIN_NUC_PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
| 0.1 | 1.7 | NABA_PROTEOGLYCANS | Genes encoding proteoglycans |
| 0.1 | 0.7 | PID_IL8_CXCR1_PATHWAY | IL8- and CXCR1-mediated signaling events |
| 0.0 | 0.2 | PID_TCPTP_PATHWAY | Signaling events mediated by TCPTP |
| 0.0 | 0.3 | PID_IL2_PI3K_PATHWAY | IL2 signaling events mediated by PI3K |
| 0.0 | 0.7 | PID_ALPHA_SYNUCLEIN_PATHWAY | Alpha-synuclein signaling |
| 0.0 | 0.2 | PID_WNT_CANONICAL_PATHWAY | Canonical Wnt signaling pathway |
| 0.0 | 0.1 | PID_MAPK_TRK_PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
| 0.0 | 0.8 | PID_HEDGEHOG_2PATHWAY | Signaling events mediated by the Hedgehog family |
| 0.0 | 1.4 | PID_P53_REGULATION_PATHWAY | p53 pathway |
| 0.0 | 1.3 | PID_NOTCH_PATHWAY | Notch signaling pathway |
| 0.0 | 0.7 | PID_ARF_3PATHWAY | Arf1 pathway |
| 0.0 | 0.4 | PID_INTEGRIN_A9B1_PATHWAY | Alpha9 beta1 integrin signaling events |
| 0.0 | 3.2 | NABA_ECM_REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
| 0.0 | 0.3 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.0 | 0.9 | PID_CASPASE_PATHWAY | Caspase cascade in apoptosis |
| 0.0 | 0.3 | PID_CONE_PATHWAY | Visual signal transduction: Cones |
| 0.0 | 0.9 | PID_PLK1_PATHWAY | PLK1 signaling events |
| 0.0 | 0.1 | PID_FAS_PATHWAY | FAS (CD95) signaling pathway |
| 0.0 | 0.3 | PID_ATR_PATHWAY | ATR signaling pathway |
| 0.0 | 0.0 | PID_AR_NONGENOMIC_PATHWAY | Nongenotropic Androgen signaling |
| 0.0 | 0.2 | PID_CERAMIDE_PATHWAY | Ceramide signaling pathway |
| 0.0 | 0.2 | PID_DELTA_NP63_PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
Gene overrepresentation in C2:CP:REACTOME category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.8 | 6.6 | REACTOME_APOBEC3G_MEDIATED_RESISTANCE_TO_HIV1_INFECTION | Genes involved in APOBEC3G mediated resistance to HIV-1 infection |
| 0.8 | 7.4 | REACTOME_SIGNALING_BY_FGFR3_MUTANTS | Genes involved in Signaling by FGFR3 mutants |
| 0.7 | 4.9 | REACTOME_ENDOGENOUS_STEROLS | Genes involved in Endogenous sterols |
| 0.7 | 14.5 | REACTOME_OXYGEN_DEPENDENT_PROLINE_HYDROXYLATION_OF_HYPOXIA_INDUCIBLE_FACTOR_ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
| 0.7 | 2.6 | REACTOME_ASSOCIATION_OF_LICENSING_FACTORS_WITH_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
| 0.6 | 9.3 | REACTOME_RAF_MAP_KINASE_CASCADE | Genes involved in RAF/MAP kinase cascade |
| 0.6 | 8.1 | REACTOME_CHYLOMICRON_MEDIATED_LIPID_TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
| 0.6 | 9.0 | REACTOME_REGULATION_OF_INSULIN_LIKE_GROWTH_FACTOR_IGF_ACTIVITY_BY_INSULIN_LIKE_GROWTH_FACTOR_BINDING_PROTEINS_IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
| 0.6 | 13.3 | REACTOME_ACTIVATION_OF_BH3_ONLY_PROTEINS | Genes involved in Activation of BH3-only proteins |
| 0.5 | 8.6 | REACTOME_G1_S_SPECIFIC_TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
| 0.5 | 11.5 | REACTOME_FORMATION_OF_TUBULIN_FOLDING_INTERMEDIATES_BY_CCT_TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
| 0.5 | 0.5 | REACTOME_MRNA_DECAY_BY_3_TO_5_EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
| 0.5 | 7.5 | REACTOME_METABOLISM_OF_POLYAMINES | Genes involved in Metabolism of polyamines |
| 0.4 | 10.2 | REACTOME_HORMONE_SENSITIVE_LIPASE_HSL_MEDIATED_TRIACYLGLYCEROL_HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
| 0.4 | 1.3 | REACTOME_FGFR2C_LIGAND_BINDING_AND_ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
| 0.4 | 14.3 | REACTOME_PROSTACYCLIN_SIGNALLING_THROUGH_PROSTACYCLIN_RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
| 0.4 | 14.6 | REACTOME_GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
| 0.4 | 0.4 | REACTOME_LATENT_INFECTION_OF_HOMO_SAPIENS_WITH_MYCOBACTERIUM_TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
| 0.4 | 2.8 | REACTOME_E2F_ENABLED_INHIBITION_OF_PRE_REPLICATION_COMPLEX_FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
| 0.4 | 1.2 | REACTOME_NEGATIVE_REGULATION_OF_THE_PI3K_AKT_NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
| 0.4 | 0.4 | REACTOME_DESTABILIZATION_OF_MRNA_BY_BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
| 0.4 | 7.0 | REACTOME_RNA_POL_I_PROMOTER_OPENING | Genes involved in RNA Polymerase I Promoter Opening |
| 0.4 | 5.5 | REACTOME_SIGNALING_BY_NODAL | Genes involved in Signaling by NODAL |
| 0.4 | 6.0 | REACTOME_G0_AND_EARLY_G1 | Genes involved in G0 and Early G1 |
| 0.4 | 3.2 | REACTOME_GLUCURONIDATION | Genes involved in Glucuronidation |
| 0.4 | 32.2 | REACTOME_RESPIRATORY_ELECTRON_TRANSPORT_ATP_SYNTHESIS_BY_CHEMIOSMOTIC_COUPLING_AND_HEAT_PRODUCTION_BY_UNCOUPLING_PROTEINS_ | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
| 0.3 | 2.4 | REACTOME_AQUAPORIN_MEDIATED_TRANSPORT | Genes involved in Aquaporin-mediated transport |
| 0.3 | 3.7 | REACTOME_AMINE_DERIVED_HORMONES | Genes involved in Amine-derived hormones |
| 0.3 | 35.6 | REACTOME_PEPTIDE_CHAIN_ELONGATION | Genes involved in Peptide chain elongation |
| 0.3 | 0.7 | REACTOME_REGULATION_OF_AMPK_ACTIVITY_VIA_LKB1 | Genes involved in Regulation of AMPK activity via LKB1 |
| 0.3 | 4.7 | REACTOME_PURINE_RIBONUCLEOSIDE_MONOPHOSPHATE_BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
| 0.3 | 7.3 | REACTOME_PTM_GAMMA_CARBOXYLATION_HYPUSINE_FORMATION_AND_ARYLSULFATASE_ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
| 0.3 | 1.3 | REACTOME_CELL_DEATH_SIGNALLING_VIA_NRAGE_NRIF_AND_NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
| 0.3 | 5.1 | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
| 0.3 | 0.6 | REACTOME_LYSOSOME_VESICLE_BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
| 0.3 | 5.3 | REACTOME_MITOCHONDRIAL_FATTY_ACID_BETA_OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
| 0.3 | 10.2 | REACTOME_G1_PHASE | Genes involved in G1 Phase |
| 0.3 | 9.8 | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
| 0.3 | 4.6 | REACTOME_CD28_DEPENDENT_VAV1_PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
| 0.3 | 17.0 | REACTOME_REGULATION_OF_ORNITHINE_DECARBOXYLASE_ODC | Genes involved in Regulation of ornithine decarboxylase (ODC) |
| 0.3 | 2.7 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_ATF6_ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
| 0.3 | 0.6 | REACTOME_ACTIVATED_POINT_MUTANTS_OF_FGFR2 | Genes involved in Activated point mutants of FGFR2 |
| 0.3 | 3.5 | REACTOME_REGULATION_OF_IFNG_SIGNALING | Genes involved in Regulation of IFNG signaling |
| 0.3 | 2.9 | REACTOME_TETRAHYDROBIOPTERIN_BH4_SYNTHESIS_RECYCLING_SALVAGE_AND_REGULATION | Genes involved in Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation |
| 0.3 | 6.5 | REACTOME_PYRUVATE_METABOLISM | Genes involved in Pyruvate metabolism |
| 0.3 | 4.8 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_MULTIPLE_NUCLEOTIDE_PATCH_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the multiple-nucleotide patch replacement pathway |
| 0.3 | 2.2 | REACTOME_CYCLIN_A_B1_ASSOCIATED_EVENTS_DURING_G2_M_TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
| 0.3 | 3.1 | REACTOME_DESTABILIZATION_OF_MRNA_BY_AUF1_HNRNP_D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
| 0.3 | 7.2 | REACTOME_INFLUENZA_VIRAL_RNA_TRANSCRIPTION_AND_REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
| 0.3 | 5.2 | REACTOME_ACTIVATION_OF_GENES_BY_ATF4 | Genes involved in Activation of Genes by ATF4 |
| 0.3 | 2.7 | REACTOME_NFKB_IS_ACTIVATED_AND_SIGNALS_SURVIVAL | Genes involved in NF-kB is activated and signals survival |
| 0.3 | 12.9 | REACTOME_CLASS_B_2_SECRETIN_FAMILY_RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
| 0.3 | 5.6 | REACTOME_RNA_POL_III_TRANSCRIPTION_TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
| 0.3 | 1.8 | REACTOME_PROLACTIN_RECEPTOR_SIGNALING | Genes involved in Prolactin receptor signaling |
| 0.2 | 6.0 | REACTOME_CHOLESTEROL_BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
| 0.2 | 2.9 | REACTOME_PREFOLDIN_MEDIATED_TRANSFER_OF_SUBSTRATE_TO_CCT_TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
| 0.2 | 0.2 | REACTOME_SCF_BETA_TRCP_MEDIATED_DEGRADATION_OF_EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
| 0.2 | 3.5 | REACTOME_P38MAPK_EVENTS | Genes involved in p38MAPK events |
| 0.2 | 5.3 | REACTOME_ACTIVATION_OF_THE_PRE_REPLICATIVE_COMPLEX | Genes involved in Activation of the pre-replicative complex |
| 0.2 | 2.8 | REACTOME_VEGF_LIGAND_RECEPTOR_INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
| 0.2 | 12.7 | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
| 0.2 | 6.0 | REACTOME_STRIATED_MUSCLE_CONTRACTION | Genes involved in Striated Muscle Contraction |
| 0.2 | 0.9 | REACTOME_ANTIGEN_PROCESSING_CROSS_PRESENTATION | Genes involved in Antigen processing-Cross presentation |
| 0.2 | 2.7 | REACTOME_GAP_JUNCTION_ASSEMBLY | Genes involved in Gap junction assembly |
| 0.2 | 2.2 | REACTOME_ABACAVIR_TRANSPORT_AND_METABOLISM | Genes involved in Abacavir transport and metabolism |
| 0.2 | 3.8 | REACTOME_REGULATION_OF_GENE_EXPRESSION_IN_BETA_CELLS | Genes involved in Regulation of gene expression in beta cells |
| 0.2 | 0.2 | REACTOME_APC_CDC20_MEDIATED_DEGRADATION_OF_NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
| 0.2 | 0.2 | REACTOME_DESTABILIZATION_OF_MRNA_BY_KSRP | Genes involved in Destabilization of mRNA by KSRP |
| 0.2 | 2.8 | REACTOME_ACTIVATION_OF_RAC | Genes involved in Activation of Rac |
| 0.2 | 3.4 | REACTOME_MRNA_DECAY_BY_5_TO_3_EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
| 0.2 | 1.2 | REACTOME_ELEVATION_OF_CYTOSOLIC_CA2_LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
| 0.2 | 2.2 | REACTOME_SEMA3A_PAK_DEPENDENT_AXON_REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
| 0.2 | 2.2 | REACTOME_ER_PHAGOSOME_PATHWAY | Genes involved in ER-Phagosome pathway |
| 0.2 | 0.8 | REACTOME_SLBP_DEPENDENT_PROCESSING_OF_REPLICATION_DEPENDENT_HISTONE_PRE_MRNAS | Genes involved in SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs |
| 0.2 | 3.2 | REACTOME_SYNTHESIS_SECRETION_AND_INACTIVATION_OF_GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
| 0.2 | 8.9 | REACTOME_MITOCHONDRIAL_PROTEIN_IMPORT | Genes involved in Mitochondrial Protein Import |
| 0.2 | 1.9 | REACTOME_KERATAN_SULFATE_DEGRADATION | Genes involved in Keratan sulfate degradation |
| 0.2 | 4.0 | REACTOME_SYNTHESIS_AND_INTERCONVERSION_OF_NUCLEOTIDE_DI_AND_TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
| 0.2 | 3.7 | REACTOME_RNA_POL_II_TRANSCRIPTION_PRE_INITIATION_AND_PROMOTER_OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
| 0.2 | 2.2 | REACTOME_REGULATION_OF_MRNA_STABILITY_BY_PROTEINS_THAT_BIND_AU_RICH_ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
| 0.2 | 0.2 | REACTOME_AUTODEGRADATION_OF_THE_E3_UBIQUITIN_LIGASE_COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
| 0.2 | 4.9 | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
| 0.2 | 7.2 | REACTOME_PHASE_II_CONJUGATION | Genes involved in Phase II conjugation |
| 0.2 | 1.4 | REACTOME_GRB2_SOS_PROVIDES_LINKAGE_TO_MAPK_SIGNALING_FOR_INTERGRINS_ | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
| 0.2 | 0.7 | REACTOME_ANDROGEN_BIOSYNTHESIS | Genes involved in Androgen biosynthesis |
| 0.2 | 3.2 | REACTOME_PYRUVATE_METABOLISM_AND_CITRIC_ACID_TCA_CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
| 0.2 | 5.5 | REACTOME_TIGHT_JUNCTION_INTERACTIONS | Genes involved in Tight junction interactions |
| 0.2 | 2.5 | REACTOME_FORMATION_OF_THE_TERNARY_COMPLEX_AND_SUBSEQUENTLY_THE_43S_COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
| 0.2 | 1.7 | REACTOME_HDL_MEDIATED_LIPID_TRANSPORT | Genes involved in HDL-mediated lipid transport |
| 0.2 | 0.8 | REACTOME_THROMBIN_SIGNALLING_THROUGH_PROTEINASE_ACTIVATED_RECEPTORS_PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
| 0.2 | 7.2 | REACTOME_TRANSLATION | Genes involved in Translation |
| 0.2 | 2.4 | REACTOME_PURINE_SALVAGE | Genes involved in Purine salvage |
| 0.2 | 1.5 | REACTOME_SIGNAL_REGULATORY_PROTEIN_SIRP_FAMILY_INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
| 0.2 | 3.0 | REACTOME_KINESINS | Genes involved in Kinesins |
| 0.1 | 13.2 | REACTOME_MITOTIC_M_M_G1_PHASES | Genes involved in Mitotic M-M/G1 phases |
| 0.1 | 3.2 | REACTOME_RNA_POL_I_TRANSCRIPTION | Genes involved in RNA Polymerase I Transcription |
| 0.1 | 2.2 | REACTOME_SIGNAL_ATTENUATION | Genes involved in Signal attenuation |
| 0.1 | 3.9 | REACTOME_ENDOSOMAL_SORTING_COMPLEX_REQUIRED_FOR_TRANSPORT_ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
| 0.1 | 17.1 | REACTOME_MRNA_SPLICING | Genes involved in mRNA Splicing |
| 0.1 | 1.0 | REACTOME_ACTIVATION_OF_ATR_IN_RESPONSE_TO_REPLICATION_STRESS | Genes involved in Activation of ATR in response to replication stress |
| 0.1 | 3.0 | REACTOME_METABOLISM_OF_PORPHYRINS | Genes involved in Metabolism of porphyrins |
| 0.1 | 1.2 | REACTOME_TRYPTOPHAN_CATABOLISM | Genes involved in Tryptophan catabolism |
| 0.1 | 3.1 | REACTOME_OTHER_SEMAPHORIN_INTERACTIONS | Genes involved in Other semaphorin interactions |
| 0.1 | 0.3 | REACTOME_FORMATION_OF_THE_HIV1_EARLY_ELONGATION_COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
| 0.1 | 1.9 | REACTOME_KERATAN_SULFATE_BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
| 0.1 | 1.6 | REACTOME_EXTENSION_OF_TELOMERES | Genes involved in Extension of Telomeres |
| 0.1 | 2.4 | REACTOME_AMINO_ACID_SYNTHESIS_AND_INTERCONVERSION_TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
| 0.1 | 0.1 | REACTOME_INFLUENZA_LIFE_CYCLE | Genes involved in Influenza Life Cycle |
| 0.1 | 2.4 | REACTOME_PYRIMIDINE_METABOLISM | Genes involved in Pyrimidine metabolism |
| 0.1 | 2.7 | REACTOME_INSULIN_RECEPTOR_RECYCLING | Genes involved in Insulin receptor recycling |
| 0.1 | 3.0 | REACTOME_SYNTHESIS_OF_GLYCOSYLPHOSPHATIDYLINOSITOL_GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
| 0.1 | 0.6 | REACTOME_POST_CHAPERONIN_TUBULIN_FOLDING_PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
| 0.1 | 6.8 | REACTOME_COLLAGEN_FORMATION | Genes involved in Collagen formation |
| 0.1 | 1.6 | REACTOME_METABOLISM_OF_NON_CODING_RNA | Genes involved in Metabolism of non-coding RNA |
| 0.1 | 1.5 | REACTOME_GROWTH_HORMONE_RECEPTOR_SIGNALING | Genes involved in Growth hormone receptor signaling |
| 0.1 | 0.2 | REACTOME_RESOLUTION_OF_AP_SITES_VIA_THE_SINGLE_NUCLEOTIDE_REPLACEMENT_PATHWAY | Genes involved in Resolution of AP sites via the single-nucleotide replacement pathway |
| 0.1 | 0.5 | REACTOME_PURINE_METABOLISM | Genes involved in Purine metabolism |
| 0.1 | 0.7 | REACTOME_REGULATION_OF_INSULIN_SECRETION_BY_ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
| 0.1 | 0.5 | REACTOME_ADP_SIGNALLING_THROUGH_P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
| 0.1 | 3.5 | REACTOME_HS_GAG_BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
| 0.1 | 0.8 | REACTOME_GLOBAL_GENOMIC_NER_GG_NER | Genes involved in Global Genomic NER (GG-NER) |
| 0.1 | 2.0 | REACTOME_SIGNALING_BY_BMP | Genes involved in Signaling by BMP |
| 0.1 | 1.3 | REACTOME_IONOTROPIC_ACTIVITY_OF_KAINATE_RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
| 0.1 | 0.4 | REACTOME_SEMA3A_PLEXIN_REPULSION_SIGNALING_BY_INHIBITING_INTEGRIN_ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
| 0.1 | 6.1 | REACTOME_GOLGI_ASSOCIATED_VESICLE_BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
| 0.1 | 2.2 | REACTOME_PLATELET_AGGREGATION_PLUG_FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
| 0.1 | 0.6 | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | Genes involved in Regulation of beta-cell development |
| 0.1 | 2.6 | REACTOME_NCAM1_INTERACTIONS | Genes involved in NCAM1 interactions |
| 0.1 | 0.7 | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
| 0.1 | 0.8 | REACTOME_GENERATION_OF_SECOND_MESSENGER_MOLECULES | Genes involved in Generation of second messenger molecules |
| 0.1 | 1.4 | REACTOME_CONVERSION_FROM_APC_C_CDC20_TO_APC_C_CDH1_IN_LATE_ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
| 0.1 | 2.7 | REACTOME_CELL_CELL_JUNCTION_ORGANIZATION | Genes involved in Cell-cell junction organization |
| 0.1 | 0.7 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PS | Genes involved in Acyl chain remodelling of PS |
| 0.1 | 0.7 | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
| 0.1 | 1.2 | REACTOME_DEADENYLATION_DEPENDENT_MRNA_DECAY | Genes involved in Deadenylation-dependent mRNA decay |
| 0.1 | 0.4 | REACTOME_SIGNALING_BY_ERBB2 | Genes involved in Signaling by ERBB2 |
| 0.1 | 4.8 | REACTOME_NUCLEAR_RECEPTOR_TRANSCRIPTION_PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
| 0.1 | 1.1 | REACTOME_APOPTOSIS_INDUCED_DNA_FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
| 0.1 | 0.4 | REACTOME_ERKS_ARE_INACTIVATED | Genes involved in ERKs are inactivated |
| 0.1 | 1.7 | REACTOME_ANTIVIRAL_MECHANISM_BY_IFN_STIMULATED_GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
| 0.1 | 0.2 | REACTOME_DNA_REPLICATION | Genes involved in DNA Replication |
| 0.1 | 2.6 | REACTOME_ACTIVATION_OF_CHAPERONE_GENES_BY_XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
| 0.1 | 1.1 | REACTOME_DARPP_32_EVENTS | Genes involved in DARPP-32 events |
| 0.1 | 9.8 | REACTOME_ANTIGEN_PROCESSING_UBIQUITINATION_PROTEASOME_DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
| 0.1 | 0.1 | REACTOME_APC_C_CDC20_MEDIATED_DEGRADATION_OF_MITOTIC_PROTEINS | Genes involved in APC/C:Cdc20 mediated degradation of mitotic proteins |
| 0.1 | 0.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PG | Genes involved in Acyl chain remodelling of PG |
| 0.1 | 0.4 | REACTOME_PRESYNAPTIC_NICOTINIC_ACETYLCHOLINE_RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
| 0.1 | 0.3 | REACTOME_AKT_PHOSPHORYLATES_TARGETS_IN_THE_CYTOSOL | Genes involved in AKT phosphorylates targets in the cytosol |
| 0.0 | 0.3 | REACTOME_CYTOCHROME_P450_ARRANGED_BY_SUBSTRATE_TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
| 0.0 | 0.2 | REACTOME_COMMON_PATHWAY | Genes involved in Common Pathway |
| 0.0 | 0.5 | REACTOME_BILE_ACID_AND_BILE_SALT_METABOLISM | Genes involved in Bile acid and bile salt metabolism |
| 0.0 | 0.0 | REACTOME_P53_DEPENDENT_G1_DNA_DAMAGE_RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
| 0.0 | 2.4 | REACTOME_NOTCH1_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
| 0.0 | 2.3 | REACTOME_METABOLISM_OF_VITAMINS_AND_COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
| 0.0 | 0.3 | REACTOME_G_ALPHA_Z_SIGNALLING_EVENTS | Genes involved in G alpha (z) signalling events |
| 0.0 | 0.1 | REACTOME_INTRINSIC_PATHWAY | Genes involved in Intrinsic Pathway |
| 0.0 | 0.2 | REACTOME_DOWNREGULATION_OF_ERBB2_ERBB3_SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
| 0.0 | 0.1 | REACTOME_DOWNSTREAM_SIGNALING_OF_ACTIVATED_FGFR | Genes involved in Downstream signaling of activated FGFR |
| 0.0 | 0.3 | REACTOME_MICRORNA_MIRNA_BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
| 0.0 | 0.1 | REACTOME_SIGNALLING_TO_P38_VIA_RIT_AND_RIN | Genes involved in Signalling to p38 via RIT and RIN |
| 0.0 | 0.2 | REACTOME_ACYL_CHAIN_REMODELLING_OF_PC | Genes involved in Acyl chain remodelling of PC |
| 0.0 | 0.2 | REACTOME_PASSIVE_TRANSPORT_BY_AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
| 0.0 | 0.0 | REACTOME_TRAF3_DEPENDENT_IRF_ACTIVATION_PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
| 0.0 | 0.5 | REACTOME_SYNTHESIS_OF_VERY_LONG_CHAIN_FATTY_ACYL_COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
| 0.0 | 0.1 | REACTOME_TRANSPORT_OF_MATURE_MRNA_DERIVED_FROM_AN_INTRONLESS_TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
| 0.0 | 0.2 | REACTOME_HYALURONAN_METABOLISM | Genes involved in Hyaluronan metabolism |
| 0.0 | 0.3 | REACTOME_ACTIVATED_AMPK_STIMULATES_FATTY_ACID_OXIDATION_IN_MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
| 0.0 | 0.0 | REACTOME_NFKB_ACTIVATION_THROUGH_FADD_RIP1_PATHWAY_MEDIATED_BY_CASPASE_8_AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
| 0.0 | 0.2 | REACTOME_IL_2_SIGNALING | Genes involved in Interleukin-2 signaling |
| 0.0 | 0.2 | REACTOME_NEGATIVE_REGULATORS_OF_RIG_I_MDA5_SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
| 0.0 | 0.4 | REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS | Genes involved in O-linked glycosylation of mucins |
| 0.0 | 0.1 | REACTOME_SULFUR_AMINO_ACID_METABOLISM | Genes involved in Sulfur amino acid metabolism |
| 0.0 | 0.3 | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
| 0.0 | 0.1 | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | Genes involved in Initial triggering of complement |
|
|
|